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Abstract 
 
Oral colonisation by the opportunistic yeast species Candida albicans is the major 
cause of oropharyngeal candidosis (OPC) in a variety of individuals. A sub set of OPC, 
denture  induced  stomatitis  (DIS),  is  predominantly  associated  with  the  elderly 
population  is  considered  to  occur  due  to  multiple  factors,  including  improper 
denture  hygiene.  Biofilm  forming  ability  of  C.  albicans  strains  is  linked  to  high 
carriage and persistence rates following treatment among infected individuals. 
 
These  studies  aimed  to  assess  various  denture  decontamination  options  upon  C. 
albicans  biofilms  grown  on  both  polystyrene  and  acrylic  resin  surfaces.  ‘Gold 
standard’ denture hygiene regimens proved to be partially effective in reducing C. 
albicans numbers therefore combination treatments with two commercial denture 
cleansers  as  well  as  dentifrice  were  investigated.  Sequential  treatment  with 
Polident® (pH 8.6) yielded highest efficacy in biofilm inactivity with no re growth 
present  following  incubation  in  growth  medium.  Interactions  of  known 
morphological modulators upon initial biofilm formation as well as mature biofilm 
viability were also assessed. Both EDTA; a cation chelator and farnesol; a molecule 
involved in quorum sensing in C. albicans spp. demonstrated anti biofilm effects. 
Implications of fungicidal activity presented could impact upon novel anti candidal 
formulations. 
 
Finally, host immune responses related to C. albicans infection were investigated in 
vitro using OKF6 TERT2 oral epithelial cells. Release of the inflammatory marker; 
IL 8  demonstrated  that  the  biofilm  mode of  candidal  growth  results  in  elevated 
levels of host inflammation. Treatment of biofilms with Polident® (pH 7.0) denture 
cleanser did not impact upon levels of host inflammation suggesting that biofilm 
components, independent of viability lead to elevated immune responses. 
 
In conclusion, current methods for the treatment of C. albicans  biofilm forming 
species  are  inadequate  as  the  majority  of  commercially  available  ‘chemical 
cleaners’ merely inactivate the fungal biofilm without dispersing biofilm material. 
This has implications on subsequent yeast re growth and prospective infection.    II 
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1. Introduction 
 
1.1 General introduction 
 
Oropharyngeal candidosis (OPC), commonly referred to as ‘oral thrush’, is caused 
by  the  opportunistic  yeast  Candida.  OPC  typically  presents  with  white  coloured 
pseudomembraneous lesions covering large areas of the oral mucosa, tongue and 
palate (Odds, 1988).  
 
Candida spp. are considered to have a commensal relationship with the host. At 
present, it is estimated that up to 70% of individuals harbour the organism without 
detrimental effects. It is only when the host becomes immunocompromised that 
problems arise (Cannon & Chaffin, 1999). Most worryingly, the incidence of Candida 
spp. associated bloodstream infections has increased by more than 75% in the last 
30 years and is considered to remain at this elevated level until the introduction of 
new prevention measures and treatments (Jarvis, 1995; Pfaller & Wenzel, 1992). 
Although  OPC  is  rarely  associated  with  high  instances  of  mortality,  significant 
morbidity is often experienced. Such morbidity heavily burdens both the individual 
and the healthcare system (Li et al., 2007b). 
 
Symptoms of OPC include changes in taste and oral pain, which is often referred to 
as a burning sensation (Ramage et al., 2004). The consequence of such generalised 
sub clinical  symptoms  is  that  the  condition  is  often  under  diagnosed  and 
appropriate treatment therefore not administered (Akpan & Morgan, 2002). Even 
after prescription of anti fungal medication, colonisation is often re established. 
Thereafter,  problems  can  regularly  arise  if  the  underlying  reason  for 
immunosuppression is not identified or cannot be treated (Lamfon et al., 2004). 
 
One of the commonest types of OPC is the erythematous form. When associated 
with  use  of  oral  prosthetic  appliances,  this  often  leads  to  the  development  of 
denture induced stomatitis (DIS). The condition characteristically presents itself as 
erythema (inflammation) of the oral mucosa in denture wearing individuals (Odds, 
1988).  The yeast Candida albicans is implicated as the main causative organism of   3 
DIS. This is primarily due to the organism’s ability to readily adhere to and form 
resilient biofilms on both soft and hard tissues of the oral cavity (Coco et al., 2008). 
 
1.2. Oropharyngeal candidosis 
 
Clinically, the most prevalent superficial Candida infections are those associated 
with the oral mucosa. OPC can be divided into three main clinical forms, comprising 
angular cheilitis, pseudomembraneous and erythematous (Akpan & Morgan, 2002). 
This thesis will specifically concentrate on the erythematous form, of which DIS is a 
common type. 
 
1.2.1 Erythematous candidosis 
 
Generally, the condition is characterised by erythema of the oral palate and tongue 
without  the  typical  white  plaques  evident  within  the  pseudomembraneous  form 
(Palmer et al., 1996). An inflamed mucosa, particularly of the upper palate in a 
denture wearing individual, is referred to as DIS (Figure 1.1). 
 
DIS is generally considered to be caused by poor denture adaptation to the oral 
mucosa. Repeated damage to the oral mucosa by an unstable denture leads to the 
release of an inflammatory secretion from oral epithelial cells that promotes the  
colonisation and subsequent development of Candida species on the oral mucosa 
(Peltola et al., 1997; Ramage et al., 2004) 
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Figure 1.1 Inflamed palatal oral mucosa indicative of denture induced stomatitis. 
(www.swedishmedical.org/PERT/images/denture.jpg) 
 
1.2.2 Denture induced stomatitis (DIS) 
 
1.2.2.1 Introduction to DIS 
There  are  approximately  15  million  denture  wearing  individuals  in  the  United 
Kingdom  (Coulthwaite  &  Verran,  2007).  Inflammation  due  to  DIS  is  frequently 
present  in  patients  who  wear  either  full  or  partial  removable  dentures.  This 
indicates that the condition is a widespread problem that is often recurring, and 
proves to be a considerable healthcare burden (Jose et al., 2010).  
1.2.2.2 Historical background 
 
Descriptions of DIS date back to the late 1800’s (Black, 1885). Initially the term 
‘rubber sore mouth’ was chosen and subsequently renamed to ‘denture stomatitis’ 
in  1965.  This  highlighted  the  effect  of  denture  wearing  upon  oral  infection and 
ensuing inflammation of the oral mucosa (Newton, 1962; Cawson, 1965).  
 
Originally, bacteria were perceived as the principle micro organisms responsible for 
the condition. Subsequently, the link between high rates of Candida species and DIS 
was established (van Reenen, 1973). Due to high rates of oral candidal colonisation   5 
and denture wear in the aging population it is possible to comprehend why DIS is 
the most frequent form of OPC in the elderly population (Ellepola et al., 1999). 
 
1.2.2.3 Predisposing factors for DIS 
 
Predisposing factors for DIS are listed in Table 1.1 (Samaranayake, 1986; Cannon & 
Chaffin,  1999;  Farah  et  al.,  2000;  Davies  et  al.,  2006).  Poor  dietary  intake,  in 
particular deficiencies in iron or a high consumption of carbohydrate rich foods, has 
been established to worsen or prolong OPC (Cawson, 1966; Samaranayake, 1986). 
 
Research  has  elucidated  that  the  occurrence  and  severity  of  DIS  is  reduced  if 
dentures  are  routinely  removed  during  the  night.  This  is  due  to  reductions  in 
potential prolonged denture trauma and colonisation of the denture and the soft 
tissues by microorganisms during this time (Oksala, 1990). 
 
Factors  contributing  to  DIS  can  continuously  change,  therefore  the  condition  is 
considered to be frequently persistent and recurring. Indeed, it is estimated that 
approximately  11 70%  of  denture  wearers  are  affected  at  any  one  time  (Budtz 
Jorgensen, 1974; Arendorf & Walker, 1987; Barbeau et al., 2003). 
 
Table 1.1 Factors which predispose an individual to denture induced stomatitis.  
 
 
 
 
 
Factors predisposing to the development of denture induced stomatitis 
Poor oral hygiene  Xerostomia (dry mouth) 
Denture trauma  Immunosuppression 
Antibiotic Therapy  Radiation therapy 
Smoking  Diet   6 
1.2.2.4 Clinical assessment of DIS 
 
Newton’s criteria describe DIS according to severity (Newton, 1962). This ranges 
from type 0 to type 3, with 3 being the most severe presentation of the condition. 
Candidal colonisation and ensuing biofilm formation is associated with various types 
of Newton’s grade of erythema (Ramage et al., 2004; Coco et al., 2008).  Recent in 
vivo observations demonstrated that all modes; including yeast and hyphal forms of 
Candida biofilm growth are exhibited during DIS infection (Ramage et al., 2004). 
 
Newton’s scale of severity was later updated to the simplified version below, and 
these levels of oral inflammation are represented in Figure 1.2: 
 
0-  No inflammation 
1-  Localised inflammation (NT I) 
2-  Diffuse inflammation (NT II) 
3-  Granular inflammation (NT III) 
 
It has become evident that high levels of inflammation are not consistently due to 
the amount of organisms present. Other factors such as poor oral hygiene appear to 
play a crucial role (Coco et al., 2008). 
 
 
Figure 1.2 Newton’s Type scale for the classification of inflammation present in 
DIS.  I)  Slight  inflammation  II)  Diffuse  inflammation  III)  Severe  inflammation  are 
shown in the figure (Barbeau et al., 2003) 
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1.2.2.5 Candidal adhesion to dentures 
 
Strong attachment and subsequent biofilm formation of Candida spp. on surfaces is 
fundamental for yeast survival. It is commonly accepted that adherence of yeast to 
the denture surface is facilitated by the formation of a salivary pellicle on teeth 
and  dentures  alike  (Edgerton  et  al.,  1993).  Candidal  attachment  has  also  been 
reported to occur directly, without initial salivary pellicle formation. So far this 
process has only been examined in vitro as presence of a salivary pellicle cannot be 
avoided in the oral cavity (Radford et al., 1999).  
 
The main stages involved in adhesion and colonisation include: 
·  Movement to surface through diffusion or chemotaxis 
·  Initial adhesion through van der Waal’s forces followed by surface 
free energies between the yeast and surface 
·  Attachment  involving  yeast  cell  wall  components  such  as 
polysaccharides adhering to various receptors in plaque which is 
composed mainly of saliva and bacteria 
·  Colonisation and biofilm formation (Radford et al., 1999) 
 
 
The initial stage of adherence is thought to occur through surface free energies 
between  the  impression  surface  of  the  denture  and  microorganism.  The  second 
stage is more precise, involving specific microbial adhesives which bind strongly to 
receptors  on  the  denture  surface  (Nevzatoglu  et  al.,  2007).  These  adhesins  are 
candidal surface proteins that have been found to be associated with germ tube 
attachment to plastic surfaces (Tronchin et al., 1988). Tronchin and colleagues did 
not specify the adhesin group involved, but novel research implicates candidal host 
surface adherence to the agglutinin like sequences (ALS) gene family amongst other 
proteins (Hoyer, 2001). It is considered that there are 8 cell surface proteins in the 
family  and  expression  of  corresponding  genes  is  linked  to  greater  pathogenicity 
within C. albicans strains (Zhao et al., 2003). 
 
   8 
Together, these adhesion mechanisms prevent removal of the organism from both 
denture  surfaces  and  the  oral  mucosa  by  the  host’s  physical  innate  defence 
mechanisms,  such  as  saliva.  Furthermore,  manual  removal  of  Candida  spp.  by 
brushing the denture surface is made more difficult (Ramage et al., 2004).  
 
Acrylic resin dentures are commonly manufactured from polymethylmethacrylate 
(PMMA) and it is well documented that surface ‘roughness’ is an important factor 
for microbial adhesion. Generally, rougher acrylic surfaces are associated with high 
Candida yields (Nevzatoglu et al., 2007; Yamauchi et al., 1990). This is considered 
to be related to contact sensing or ‘thigmotropism’ of Candida spp. enabling growth 
of hyphae along irregularities or cracks in the denture material (Nikawa et al., 1998; 
Ramage  et  al.,  2004).  This  subsequently  results  in  maximum  protection  of  the 
microorganism from physical cleansing and aids retention to the denture surface 
(Taylor et al., 1998; Watts et al., 1998).   
 
Dentures provide a reservoir for growth of micro organisms, as well as facilitating 
candidal contact to adjacent oral mucosa. It is also considered that yeast numbers 
on denture surfaces are higher than those colonising the oral mucosa (Davenport, 
1970). This is due in part to the development of anaerobic and acidic conditions in 
close  proximity  to  the  tissue  covered  by  the  denture.  Such  conditions  facilitate 
growth of micro organisms (Budtz Jorgensen, 1974). Furthermore, salivary flow to 
the palate is frequently impaired resulting in lower clearance of micro organisms 
than in dentate individuals (Lamfon et al., 2004). Most importantly, the presence of 
denture  plaque;  a  diverse  biofilm  structure,  consisting  of  various  oral  micro 
organisms  in  addition  to  Candida  spp.  is  considered  to  be  a  major  contributing 
factor to candidal retention on dentures (Chandra et al., 2001b). 
 
As previously stated, saliva is an important host innate defence mechanism. Various 
in vitro studies have illustrated that coating of acrylic resin with saliva reduces 
microbial  adherence due  to  blocking  of  interactions  between  yeast  and  denture 
surface  (Moura  et  al.,  2006;  Samaranayake  &  MacFarlane,  1980).  However,  a 
disparity  in  research  findings  is  apparent  as  various  sources  contradict  this 
information and suggest that a saliva coating increases candidal binding to surfaces   9 
(Vasilas  et  al.,  1992).    Saliva  acts  to  physically  remove  organisms  and  contains 
active substances such as lysozyme and lactoferrin which inhibit candidal adhesion 
to and colonisation of oral surfaces (Pereira Cenci et al., 2008).  Interestingly, not 
all  components  of  saliva  are  considered  to  hinder  the  organism.  In  particular, 
binding  of  C.  albicans  to  a  specific  site  in  mucin  has  been  described,  which 
facilitates  binding  to  saliva  coated  surfaces  (Edgerton  et  al.,  1993;  Hoffman  & 
Haidaris, 1993). 
 
1.3. Candida species and disease 
 
1.3.1 Overview of Candida species infections 
 
Candida spp. are a common human commensal and generally do not cause harm to 
the host (Akpan & Morgan, 2002; Ramage et al., 2004).  Incidence of infections 
tends to increase when host defences are compromised. HIV and AIDS patients in 
addition to the elderly and cancer sufferers commonly experience higher rates of 
pseudomembraneous and erythematous candidosis compared to healthy individuals 
(Palmer et al., 1996; Davies et al., 2006).   
 
Candida spp. are also responsible for causing a quarter of nosocomial bloodstream 
infections (Pfaller et al., 1998). This is thought to be mainly due to formation of 
biofilms  on  medical  devices,  which  consequently  results  in  limited  treatment 
options. A high level of biofilm associated resistance to antifungals represents a 
significant  hurdle  for  the  management  of  such  systemic  infections  (Kojic  & 
Darouiche, 2004).  
 
Other  than  bloodstream  infections,  Candida  associated  problems  include  intra 
abdominal and urinary tract infections (Pappas et al., 2004). Epidemiology studies 
reveal that mortality rates for patients with invasive candidiasis are as high as 60% 
(Voss et al., 1997; Wey et al., 1989). It is apparent that there is a continual need 
for surveillance and research into all forms of Candida infections due to extremely 
high prevalence and associated morbidity and mortality.  
   10 
1.3.2 Candida albicans and the human host 
 
C. albicans is a commensal organism with the ability to become opportunistic when 
conditions  become  favourable.  The  yeast  is  commonly  isolated  from  30 40%  of 
healthy individuals and increases to 50 70% for those who wear dentures (Odds, 
1988; Akpan & Morgan, 2002). The organism generally resides in the gastrointestinal 
and genitourinary tracts of healthy individuals. In certain circumstances, such as a 
shift in normal microflora due to antibiotic use, overgrowth of the microorganism 
can occur (Akpan & Morgan, 2002; Pappas et al., 2004).  
 
Various  Candida  spp.  have  been  implicated  in  oropharyngeal  candidosis  but  C. 
albicans is considered to be the most pathogenic (Budtz Jorgensen, 1974). Studies 
identify that numerous virulence factors are present which lead to both successful 
commensal carriage as well as dissemination to pathogenic disease. One such factor 
is that C. albicans has been found to have better adhesive properties than other 
Candida species (Calderone & Braun, 1991). In addition, the pathogen is known to 
secrete two types of hydrolytic enzymes (proteinases and phopholipases) which are 
crucial for the breakdown of peptide bonds and phospholipids in the host’s tissues 
(Sugita et al., 2002). This is discussed further in Section 1.4.3. 
 
As well as superficial presentations observed within the oral cavity, C. albicans is 
also  an  important  pathogen  contributing  towards  systemic  disease.  Major  health 
implications occur when C. albicans breaches the epithelial barrier and enters the 
bloodstream.  The  commonest  types  of  systemic  candidal  infection  include 
bloodstream infections, catheter infections, intra abdominal infections and urinary 
tract infections (Pappas et al., 2004). 
 
1.3.3 Other common Candida species 
 
Twenty  Candida  species  are  considered  to  be  of  medical  significance  (Akpan  & 
Morgan, 2002). Of these, C. albicans, C. glabrata and C. tropicalis represent more 
than 80% of clinical isolates (Odds, 1988).                                                   
   11 
C.  glabrata  is  the  second  most  prevalent  commensal  Candida  species  found  in 
healthy individuals after C. albicans (Coco et al., 2008; Pereira Cenci et al., 2008). 
This  documented  high  prevalence  may  be  in  part  attributed  to  C.  glabrata’s 
resistance to azole antifungal medications (Sanglard et al., 1999). In comparison, 
other Candida species are highly susceptible to azoles. This adaptation means that 
systemic infections due to C. glabrata often result in elevated mortality rates as 
other treatment options need to be sought (Cate et al., 2009; Li et al., 2007b). 
 
Although high numbers of both C. glabrata and C. albicans occur commensally and 
in pathogenic infection, significant differences in interaction with the host have 
been documented. C. albicans relies mainly on dimorphic switching between yeast 
and hyphal forms as well as secretion of adhesins for attachment to host surfaces 
(Kaur et al., 2005; Whiteway & Oberholzer, 2004). Interestingly, adhesion to host 
cells is reportedly better developed in C. albicans strains while C. glabrata strains 
possess stronger adhesion attributes in relation to denture acrylic (Biasoli et al., 
2002; Luo & Samaranayake, 2002).  
 
Release of degradative enzymes such as proteinases and phospholipases is present 
in both species, although it is documented as being higher in C. albicans strains 
(Chakrabarti et al., 1991; Samaranayake et al., 1994).  
Although  C.  albicans  has  typically  been  demonstrated  as  the  most  frequently 
isolated Candida species, a recent shift has been reported in which non albicans 
species are being regularly isolated from the oral mucosa of healthy individuals as 
well as DIS sufferers (Coco et al., 2008). Apart from the species mentioned above, C. 
parapsilosis, C. krusei and C. dubliniensis are frequent oral inhabitants associated 
with OPC (Pereira Cenci et al., 2008; Cate et al., 2009). The recent documented 
increase in C. dubliniensis spp. isolated from OPC patients is due, in part, to the 
formation  of  pseudohyphae  by  this  species.  Pseudohyphae  formation  leads  to 
biofilm  development  on  acrylic  surfaces  within  the  oral  cavity  (Ramage  et  al., 
2001b).  It  is  the  ability  of  Candida  species  to  form  resilient  biofilms  which 
facilitates success as an opportunistic pathogen (Chandra et al., 2001a; Mukherjee 
& Chandra, 2004). 
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1.4. Biofilm formation  
 
1.4.1 Introduction to biofilm formation 
 
A biofilm can be defined as a heterogeneous community of cells, attached to a 
surface  and  enclosed  in  an  extra polymeric  matrix  (Ramage  et  al.,  2002a).  A 
considerable proportion of infections are a result of biofilm development (Potera, 
1999). Apart from formation on dentures and in dental plaque, Candida biofilms are 
known to grow readily on other artificial devices including catheters and prosthetic 
limbs.  This  is  a  serious  health  care  burden  as  biofilm  development  on  medical 
implants and appliances leads to a high proportion of nosocomial infections, which 
are  often  life  threatening  (Cateau  et  al.,  2008).  Frequently,  the  only  clinical 
solution is removal of the device and treatment with antibiotics and/ or antifungals 
to clear the infection (Kojic & Darouiche, 2004).  
 
1.4.2 Morphological stages involved in biofilm progression 
 
C. albicans is considered to be a dimorphic fungus which can undergo morphological 
changes when triggered by environmental queues such as a temperature of 37ºC 
and  CO2  levels  of  5.5%  (Karkowska Kuleta  et  al.,  2009).  Stages  of  biofilm 
progression begin  with  germ  tube  formation  which is  the initial  stage  of  hyphal 
development  (Cannon  &  Chaffin,  1999).  This  occurs  following  location  of  an 
appropriate surface for colonisation. Pseudohyphae are an intermediate between 
yeast  and  hyphal  cell  whereby  cells  remain  attached  to  each  other  but  vary  in 
shape (Cate et al., 2009; Odds, 1988). This stage occurs at around 4 hours following 
attachment to the surface (Ramage et al., 2001c). Hyphae are essential for mature 
biofilm development as they, alongside the extracellular material play a part in 
upholding  the  general  structure,  drug  resistance  and  adhesive  properties  of  the 
biofilm  (Chandra  et  al.,  2001b).  True  hyphae  are  present  at  around  8  hours 
following adhesion (Ramage et al., 2001c). Morphological stages of C. albicans are 
represented in Figure 1.3 
 
   13 
 
Figure 1.3: Stages of biofilm progression. Early stage occurs between 0 and 11 
hours  and  results  in  initial  hyphae  formation.  Production  of  matrix  material  in 
intermediate  stage  (12 30  hours)  ensures  that  the  biofilm  gains  structure  and 
resilience. The final stage of maturation at 31 72 hours results in a resilient three 
dimensional structure (Ramage et al., 2009). 
 
1.  Early phase: Adherence of yeast cells to surface. This can occur up to 11 
hours after initial colonisation. Initiation of hyphae formation. 
2.  Intermediate phase: Budding yeast cells transform to hyphal cells through 
phenotypic switching. Matrix material is produced due to differential gene 
expression and subsequent production of enzymes involved in carbohydrate 
synthesis. A monolayer structure is achieved 12 to 30 hours after colonisation. 
3.  Maturation phase: Three dimensional structure is achieved through further 
growth  and  production  of  extra polymeric  matrix  which  encloses  yeast, 
pseudohyphae and hyphae forms. Microcolonies of yeast form the basal layer 
with  networks  of  hyphal  cells  lining  the  top  of  the biofilm.     Together a 
resilient biofilm structure formed after 31 to 72 hours (Chandra et al., 2001a; 
Kruppa, 2009; Lamfon et al., 2004; Ramage et al., 2001c). 
 
1.4.3 Phenotypic switching and gene expression related to pathogenicity 
 
The  phenotype  of  a  Candida  biofilm  can  alter  reversibly  in  response  to 
environmental changes including alterations in temperature, pH and the presence 
of serum ( Odds, 1988; Cate et al., 2009). Alterations such as a rough or fringed 
appearance to the phenotype of a colony occur relatively frequently. In fact, such 
events are described as occurring at a rate of 1 change per 10
1 10
4 colonies (Slutsky   14 
et al., 1985). It is understood that cells which remain as just one of either yeast or 
hyphal forms have limited virulence traits (Murad et al., 2001).  
 
A widely researched phenotypic switching event present in some C. albicans strains 
is ‘white opaque switching’ as it occurs in high frequency and can be observed at 
the microscopic level (Anderson & Soll, 1987). This type of switching not only assists 
the fungus in reproduction but also has pathogenicity implications as cells in both 
white  and  opaque  transitions  have  been  found  to  have  increased  virulence  in 
different environments (Kvaal et al., 1999). The overall goal of such phenotypic 
switching  events  is  to  increase  chances  of  pathogenicity  when  the  organism  is 
introduced to a new environment such as a new host. 
Phenotypic alterations also prove crucial in the pathogen’s ongoing development of 
resistance to a wide range of antifungals (Mukherjee & Chandra, 2004). In particular, 
the  CDR3  drug  resistance  gene  is  expressed  during  the  opaque  stage  of  white 
opaque switching of a strain of C. albicans. The CDR gene family are associated 
with efflux pump activity and subsequent resistance to fluconazole (Balan et al., 
1997). 
 
Switching  events  have  also  been  implicated  in  controlling  genes  encoding 
proteolytic  enzymes  (in  particular  SAP1  and  SAP3)  which  are  vital  for  virulence 
attributes characteristic of C. albicans  (Hube et al., 1994) (Described further in 
Section 1.4.4). It is the release of enzymes which is responsible for the majority of 
the tissue damage seen in cases of DIS (Hube, 1996; Rajendran et al., 2010).   
 
1.4.4 Degradative Enzymes 
 
Along  with  Candida  species,  many  other  microorganisms  are  known  to  secrete 
enzymes which facilitate disease progression. Collectively, it is proteolytic enzymes 
which are most commonly associated with C. albicans virulence (Naglik et al., 2003).  
 
Four main types of these proteinases are widely known; these are aspartyl, serine 
and cysteine proteinases and metalloproteinases (Barrett & Rawlings, 1991). The 
employment of proteolytic enzymes by Candida species has been well documented.   15 
In particular, the secreted aspartyl proteinases (Sap) family which is encoded by 10 
Sap genes is an important virulence factor. Sap production is also characteristic of 
several non albicans species including C. tropicalis and C. parapsilosis (Monod et 
al., 1994). It is considered that the secretion of these enzymes is directly linked to 
the pathogenicity of a species as lesser or non pathogenic Candida species do not 
express Sap genes (Naglik et al., 2003). In particular, during hyphal stages of C. 
albicans development Saps 4, 5 and 6 are expressed (Hube, 1996). 
 
Along  with  the  production  of  Sap  proteases,  Candida  species  also  exhibit 
phospholipase and haemolysin activity. Increased production of these enzymes has 
been  demonstrated  in  biofilm  forming  isolates  (Rajendran  et  al.,  2010). 
Phospholipase activity of C. albicans isolates is relatively high. 30 100% of strains 
taken from various infection sites including blood and urine were found to possess 
phospholipase activity (Price et al., 1982). The role of this enzyme is not yet fully 
understood  (Tsang  et  al.,  2007).  The  function  of  haemolysin  relates  to  iron 
acquisition of the fungus. Iron is a key substrate for the majority of microorganisms 
and a role for this element has been described in C. albicans hyphal penetration 
when associated with systemic candidiasis (Manns et al., 1994). These hydrolytic 
enzymes,  in  combination  with  cell  wall  antigens,  act  as  potent  mediators  of 
inflammation, which results in the erythema and tissue destruction associated with 
host pathogen interactions.   
 
1.4.5 Host pathogen interactions 
 
1.4.5.1 Introduction to host pathogen interactions 
 
Candida  species  may  cause  harm  to  the  host  if  conditions  for  adherence  and 
subsequently multiplication become favourable (Section 1.2). The role of the oral 
environment is to protect the oral cavity from adherence of Candida spp. to both 
hard surfaces, such as the teeth and dentures, as well as to the soft epithelium 
(Decanis et al., 2009). If oral tissues are successfully infected by a micro organism, 
inflammation and tissue destruction may ensue as illustrated in Figure 1.4.   16 
(Davenport et al., 2001) 
Figure 1.4 Biofilm formation resulting in trauma and consequential inflammation.  
 
Host  detection  of  invading  microorganisms  occurs  primarily  through  Toll like 
receptors which are located on host cells such as epithelial cells (Takeda & Akira, 
2004).  Activation  of  Toll like  receptors  leads  to  a  plethora  of  down stream 
processes which are required for host defence (Akira & Takeda, 2004) 
 
One of the main host responses consists of leukocyte recruitment which is followed 
by  a  release  of  inflammatory  cytokines  (Mencacci  et  al.,  2000).  It  is  well 
established that IL 6, IL 8, and TNF α are the predominant cytokines released in 
response to Candida infection (Mostefaoui et al., 2004). In particular, an increase in 
IL 8 release has been documented to occur in response to epithelial cell contact 
with C. albicans hyphal cells (Dongari Bagtzoglou & Kashleva, 2003). 
 
Other than innate immunity, the adaptive immune response is also thought to be 
involved in host protection against mucosal Candida spp. infections. Sources often 
demonstrate contradictory information in regard to the anti candidal role for cell 
mediated immunity (Fidel et al., 1993), but a particular study reported that Th1 
CD4+ T cells have been implicated in a strong cell mediated host defence against 
candidosis in a mouse model (Cenci et al., 1995). 
 
   17 
1.4.5.2. Current in vitro research 
 
The oral epithelium is an effective first line of host defence with both in vitro and 
in vivo studies having seldom been able to identify candidal penetration further 
than the stratum spinosum (Reichart et al., 1995; Sundstrom et al., 2002). Studies 
indicate that the epithelium can act as a thorough anti candidal barrier in healthy 
hosts but immunocompromised individuals, such as those infected with HIV, have 
impaired oral epithelial function (Steele et al., 2000). 
 
Previously,  it  has  been  difficult  to  assess  whether  epithelial  cells  induce 
fungistatic/cidal  anti candidal  effects.  However,  it  has  been  demonstrated  that 
direct  candidal  contact  with  epithelial  cells  results  in  arresting  growth  only 
temporarily  (Nomanbhoy  et  al.,  2002).  This  therefore  means  that  other  host 
immune responses are necessary to ensure full candidal eradication. 
 
Cell  lines  are  attained,  which  best  indicate  host pathogen  interactions  in  vivo. 
OKF6/TERT human oral keratinocyte cell lines are often used to assess the immune 
response to candidal infection (Decanis et al., 2009). This cell line has recently 
been  co cultured  with  oral  keratinocytes  to  form  the  ‘engineering  human  oral 
mucosa’.  The aim  behind the  design of  this  and  other  three dimensional  model 
systems  is  to  have  a  more  direct  indication  of  the  activities  of  the  human  oral 
mucosa in response to Candida spp. infection (Rouabhia & Deslauriers, 2002). 
 
1.4.6 Quorum Sensing 
 
Biofilm formation is partially controlled by quorum sensing, which ensures that a 
correct cell density and structure can be maintained in a suitable location (Miller & 
Bassler, 2001). In vitro studies have demonstrated that yeast cell concentrations 
below 1 x 10
6 cells/mL are necessary for successful development of hyphae and 
therefore a resilient biofilm (Kruppa, 2009). An example of an important quorum 
sensing molecule is farnesol. It is a natural organic compound which is responsible 
for the shift from Candida yeast to hyphal forms (Oh et al., 2001). Farnesol inhibits 
a  primary  step  of  biofilm  development;  the  attachment  of  cells  to  a  surface   18 
(Ramage  et  al.,  2002b).  Therefore,  it  has  been  recognised  that  microorganisms 
utilise  quorum  sensing  to  ‘communicate’.  This  ensures  the  success  of  a  three 
dimensional  biofilm  which  can  maintain  a  variety  of  microbial  oral  species 
(Costerton et al., 1999). 
 
The biofilm structure benefits from a mixed species community that allows the co 
habitation of diverse bacteria and fungi. In the oral mucosa, Candida spp. most 
often exists in a mixed fungal bacterial community which aids in the survival of all 
species involved (Bamford et al., 2009).  Indeed, the adhesion of certain bacteria 
such as Escherichia coli and Streptococcus species are improved when in a mixed 
Candia biofilm (Nair & Samaranayake, 1996). The occurrence of a diverse mixed 
species lifestyle is usually due to environmental stresses such as limited nutrients 
(Palkova & Vachova, 2006). The complex molecules that are involved in cell density 
regulation may therefore be used to our advantage to help control OPC as novel 
therapeutics. 
 
1.5 Treatment of OPC 
 
As  previously  stated,  Candida  spp.  biofilm  formation  is  central  to  host  tissue 
adherence and the subsequent pathological changes. One of the major difficulties 
treating  Candida spp. infections, including OPC, is intrinsic antifungal resistance 
that is often associated with biofilm forming isolates (White et al., 1998; Chandra 
et al., 2001b; Ramage et al., 2001c). 
 
1.5.1 Use of antifungals 
 
Following diagnosis, OPC is typically treated by use of topical antifungals applied to 
the  mucosa  and/or  denture  base.  Where  resistance  to  topical  treatments  is 
observed, systemic antifungals are frequently necessary. Systemic antifungals are 
also required for individuals receiving chemotherapy (Akpan & Morgan, 2002; Patton 
et al., 2001). Commonly administered antifungal agents are listed in Table 1.2. 
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Research  has  elucidated  that  survival  in  a  biofilm  structure  leads  to  multi 
antifungal  resistance  (Ramage,  2010).  In  particular,  resistance  to  chlorhexidine, 
amphotericin B and fluconazole has been documented (Hawser & Douglas, 1995; 
Chandra  et  al.,  2001b).  In  addition  to  emerging  resistance  to  a  variety  of 
antimycotics, the efficacy of topical antifungals in the oral cavity is reduced due to 
a diluting effect of saliva (Martin, 1989). Moreover, a significant factor that results 
in inefficiency of treatment is that an individual  is often unwilling or unable to 
continue with prolonged antifungal use, for example poor compliance. This often 
leads to incomplete treatment and implications in the development of antifungal 
resistance (Ellepola & Samaranayake, 2000). This section will focus on the various 
options used to treat oral and systemic candidal infections. 
 
Table 1.2 Antifungal drugs currently used against Candida infections. Mode of 
action and target of candidal infection varies between groups 
 
Group  Mode of action  Types  Review 
Azole  Inhibition of 
ergosterol 
production in 
candidal cell 
membrane 
fluconazole, 
voriconazole, 
clotrimazole, 
miconazole 
ketonconazole 
(Sheehan et al., 
1999) 
(Kale & Johnson, 
2005) 
Polyene  Binding to 
ergosterol 
amphotericin b, 
nystatin, natamycin 
(Cornely et al., 
2006) 
Echinocandin  Inhibition of glucan 
synthesis in 
candidal cell wall 
caspofungin, 
micafungin 
(Morrison, 2006) 
(Denning, 2003) 
Allylamine  Inhibition of 
ergosterol synthesis 
terbinafine  (Jain & Sehgal, 
2000) 
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Typical treatment of OPC consists of topical nystatin or amphotericin B application 
once  or  twice  daily,  while  intravenous  fluconazole  is  administered  to 
immunocompromised  patients  (Chen  &  Sorrell,  2007).  Amphotericin  B  is  often 
favoured due its various anti candidal properties including the prevention of SAP 
enzyme production/release (Wu et al., 1996), and the ability to target candidal 
cells in yeast and hyphal forms (Ellepola & Samaranayake, 2000). A drawback of this 
antimycotic  is  the  extent  of  side  effects  experienced,  the  most  adverse  being 
nephrotoxicity (Sabra & Branch, 1990). 
 
Like amphotericin B, nystatin also targets ergosterol in the fungal cell membrane 
and leads to ‘fungal cell leakage’ (Ellepola & Samaranayake, 2000).  Nystatin is 
mainly  used  topically  and  in  tablet  form  for  the  treatment  of  oral  candidosis. 
Unfortunately, the bitter taste associated with the tablets often leads to patient 
aversion, therefore sweetened lozenges have been manufactured (Greenspan, 1994; 
Millns & Martin, 1996). Nystatin use has been described in a study for treatment of 
Candida  spp.  infected  dentures.  However,  it  was  concluded  that  soaking  of 
dentures  in  nystatin  solution  was  ineffective  as  there  was  a  retention  of  high 
numbers of Candida spp. (Banting et al., 1995). 
 
Fluconazole is considered to be effective due to relatively low levels of clinical side 
effects  as  well  as  availability  of  use  in  both  oral  and  systemic  infections. 
Nevertheless, a disadvantage is emerging resistance to various non albicans species 
including C. glabrata (Pfaller & Diekema, 2004). Voriconazole is often the drug of 
choice  for  infections  exhibiting  fluconazole  resistance,  but  this  is  primarily  for 
systemic candidiasis (Donnelly & De Pauw, 2004). Clotrimazole and miconazole are 
used in topical treatments of oral candidosis, and in particular angular cheilitis, due 
to dual activity against Candida and staphylococcal spp. (Sheehan et al., 1999). 
Studies involving the use of miconazole as a ‘denture lacquer’ have demonstrated 
an anti candidal effect in DIS sufferers (Konsberg & Axell, 1994). 
 
Significantly less research has been conducted in regard to the echinocandins as 
they  are  a  relatively  new  class  of  antimycotics  (Denning,  2003).  Caspofungin  is 
often the antifungal of choice in fluconazole resistant cases as drug safely of the   21 
echinocandins is considered to be high due to the specificity of interaction with the 
fungal  cell  wall  (Deresinski  &  Stevens,  2003).  Caspofungin  was  also  found to  be 
more effective than a number of polyenes and azoles in inhibiting biofilm forming C. 
albicans strains in vitro (Ramage, 2010). 
 
1.5.2 Alternative antifungal agents 
 
-  Chlorhexidine 
 
Various  studies  have  discussed  the  benefits  of  chlorhexidine  use  in  both  mouth 
washes  and  in  denture  decontamination  fluids  (McCourtie  et  al.,  1986).  In  the 
former,  a  concentration  of  0.2%  chlorhexidine  gluconate  has  been  reported  to 
exhibit high inhibitory effects on Candida spp. as well as other oral microbes (Addy 
&  Hunter,  1987).  In  contrast,  a  2%  solution  is  effective  for  overnight 
decontamination of dentures (Ellepola & Samaranayake, 2000). Chlorhexidine is not 
only  toxic  to  Candida  spp.,  but  also  negatively  influences  candidal  adhesion  to 
surfaces, this property is particularly useful for the treatment of dentures (Lal et 
al., 1992). This is due to the chlorhexidine property of binding to proteins from the 
yeast cytoplasm which in turn results in disintegration of the cytoplasm and cell 
death (Russell, 1986). Overall, chlorhexidine is widely recommended by dentists for 
the prevention and treatment of oral candidosis (Barasch et al., 2004). 
 
-  Sodium Hypochlorite 
 
The practice of soaking dentures in sodium hypochlorite (a key compound in bleach) 
is recommended by some dentists. Several studies have demonstrated anti candidal 
sterilising  properties  (Rudd  et  al.,  1984).  Similar  to  chlorhexidine,  Candida  spp. 
anti adhesive effects have also been demonstrated by soaking infected dentures in 
sodium hypochlorite (Webb et al., 1995). 
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1.5.3 Use of denture cleansers 
 
To  reduce  the  incidence  of  DIS,  and  therefore  subsequent  requirement  for 
antifungals, there is a raised importance in the practice of a good oral hygiene 
regimen  including  regular  decontamination  of  dentures  with  over  the  counter 
denture cleansers (Akpan & Morgan, 2002). Although regular denture cleanser use 
results  in  maintenance  of  manageable  Candida  spp.  levels,  biofilms  are  not 
effectively  disrupted.  This  can  ultimately  lead  to  candidal  overgrowth  if normal 
cleansing mechanisms are disrupted (Jose et al., 2010). 
 
Brushing  dentures  with  regular  toothbrushes  has  been  suggested  as  a  means  of 
physically removing biofilms. However, it has been demonstrated that brushing does 
not  adequately  remove  plaque  from  denture  surfaces  compared  to  soaking  in 
denture cleanser (Dills et al., 1988). Research has also revealed that regular use of 
a toothbrush upon denture surface leads to surface damage leading to irregularities 
(Ramage  et  al.,  2004;  Charman  et  al.,  2009).  As  mentioned  previously, 
imperfections in the denture surface allow increased attachment of Candida spp. 
(Charman et al., 2009).  
 
Another  method  of  denture  cleansing  utilised  by  certain  individuals  consists  of 
rinsing  dentures  in  water  alone.  Unsurprisingly  this  technique  does  not  yield 
satisfactory effects in terms of removal and inhibition of oral microorganisms (Dills 
et al., 1988; Srinivasan & Gulabani, 2010). 
 
Denture  cleansers  are  categorised  as  either  alkaline  hydrochlorites,  alkaline 
peroxides,  neutral  peroxides  with  enzymes  or  enzymes  (Budtz Jorgensen,  1979). 
Some common use, over the counter denture cleansers are listed in Table 1.3. 
 
Denture cleansers vary in composition and recommended time for soaking dentures. 
Denture cleanser solutions usually consist of a tablet dissolved in enough water to 
cover the entire denture surface. 
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    Table 1.3 Over the counter denture cleansers.  
 
DENTURE 
CLEANSER 
CATEGORY  pH  MANUFACTURER 
  Polident    Neutral/alkaline 
peroxide 
7  GlaxoSmithKline 
Efferdent  Alkaline peroxide  7.5  Pfizer 
Steradent  Alkaline peroxide    Reckitt Benckiser 
Fittydent  Alkaline peroxide    Fittydent 
International GmbH 
 
There have been many studies concentrating on the efficacy of denture cleansers in 
comparison to one another, and to other cleansing methods commonly used. The 
following highlights the most interesting studies to date. 
 
A  trend  throughout  the  literature  brings  to  light  the  effectiveness  of  alkaline 
peroxides in comparison to other categories of denture cleansers (Minagi et al., 
1987;  Dills  et  al.,  1988;  Gornitsky  et  al.,  2002).  These  include  Polident  and 
Efferdent (Table 1.3). 
 
A recent study investigated the reduction in colony forming units of Candida spp. 
and Streptococcus mutans following treatment of dentures with overnight denture 
cleansers. The outcome of the research suggested that Polident was more effective 
at  reducing  both  Candida  spp.  and  S.  mutans  numbers  compared  to  Efferdent 
denture cleanser (Gornitsky et al., 2002), which is in agreement with a more recent 
study (Uludamar et al., 2010). Another study demonstrated similar effects by both 
denture cleansers on  Candida spp. biofilms grown on denture liners. Although a 
decrease  in  colony  forming  units  was  observed,  viability  of  organisms  was  not 
sufficiently reduced which presents implications for future re growth (Vieira et al., 
2010). 
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Hypochlorite based denture cleansers, in particular sodium hypochlorite, are also 
considered  to  be  ‘efficient’,  following  studies  performed  using  acrylic  resins 
colonised with C. albicans in vitro (Montagner et al., 2009). Drawbacks of regular 
hyphochlorite use for the decontamination of surfaces often outweigh the benefits. 
Reported undesired effects include corrosive properties (Requa Clark, 1983) as well 
as an after taste present following return of dentures to patients (de Souza et al., 
2009). 
 
Generally,  establishment  of  a  regular  and  thorough  denture  cleanser  regimen  is 
considered to be satisfactory for the maintenance of low levels of Candida spp. 
thereby avoiding of the development of DIS (Gornitsky et al., 2002; Srinivasan & 
Gulabani, 2010). Indeed, a recent survey demonstrated that soaking dentures in 
denture  cleanser  was  the  most  commonly  advised  method  of  denture 
decontamination, being recommended by 72% of dentists (Dikbas et al., 2006). 
 
1.6 Summary 
 
The  oral  cavity  provides  an  environment  within  which  complex  multi species 
interactions  can  vary  significantly  between  individuals.  Candida  species,  in 
particular  C.  albicans,  can  be  isolated  from  a  large  proportion  of  healthy  and 
immunocompromised patients. Oropharyngeal candidosis is a common problem for 
individuals  with  impaired  immunity  as  well  as  the  elderly.  Denture  induced 
stomatitis, a recognised form of oral candidosis, is a significant health concern for 
denture  wearing  individuals  in  which  inflammation  of  the  mucosa  can  result  in 
discomfort amongst other symptoms.  
 
It is necessary to emphasise that correct diagnosis and treatment of DIS and OPC, in 
general,  is  crucial  for  reducing  the  incidence  of  the  condition.  Due  to  the 
limitations of the various treatment options outlined, the aim of this project was to 
concentrate on the current treatments and novel anti candidal compounds available 
and how these impact on both Candida spp. infection and the human host.  
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1.7 Hypotheses 
 
Current methods of denture care are largely ineffective at permanently inhibiting 
Candida albicans upon acrylic resin denture surfaces. This therefore leads to rapid 
colonisation and re establishment of infection within the oral cavity. It was the 
hypotheses of this study that improved denture cleanser formulations were more 
effective than current oral hygiene measures used for denture decontamination, 
and  that  these  may  have  further  health  benefits  by  reducing  subsequent 
inflammation. 
 
1.8 Aims of study 
 
1.  To evaluate the effects of treatment with a commercial denture cleanser 
upon a model system of Candida albicans biofilms. 
2.  To assess the host immune response to treated and untreated C. albicans 
biofilms. 
3.  To  consider  the  impact  of  novel  compounds  for  the  treatment  of  C. 
albicans biofilms. 
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2. Materials and Methods 
 
C. albicans strains related to denture induced stomatitis are regularly isolated from 
the mucosal surface of the upper palate as well as from the denture surfaces. The 
following experiments were designed to investigate the role of C. albicans strains in 
relation  to  the  pathogenesis  and  treatment  of  oral  candidosis,  with  particular 
emphasis on denture induced stomatitis.  
 
2.1 Clinical isolates 
 
Clinical  C.  albicans  isolates  used  in  these  investigations  were  obtained  from  a 
previous  study  on  denture  induced  stomatitis  within  Glasgow  Dental  School  and 
Hospital (Coco, 2008). All clinical isolates used in this current study were obtained 
from Microbead tubes (Prolab Diagnostics) stored at  80ºC. Isolates were originally 
obtained  from  denture  sonicate  samples  and  were  cross  referenced  to  clinically 
defined  levels  of  inflammation,  as  classified  by  the  Newton  Type  (NT)  scale 
(Newton, 1962).  Briefly, patients were classified as having healthy pink tissue (0), 
slight inflammation (NT1), reddening and pin point localised inflammation (NT2), or 
diffuse chronic inflammation (NT3). The strains used for these studies are listed in 
Table 2.1. Strains were grouped according to which Newton’s grade of inflammation 
was represented. Three type strains were also assessed for biofilm forming ability. 
Strain ATCC90028 was used as a positive control in experimentation. 
 
One C. albicans strain isolated from each of the three Newton Types and one from a 
healthy  individual  were  selected  for  use  in  the  outlined  studies  following 
experimentation in relation to good biofilm forming ability.  
 
 
 
 
 
   28 
Table  2.1  Newton’s  Type  strains  used  for  assessment  of  C.  albicans  biofilm 
formation.  
 
Control  Baseline  NT 1  NT2  NT3 
3153A  BC016  BC019  BC011  BC005 
ATCC 90028  BC052  BC030  BC015  BC070 
SC5314  BC053  BC031  BC055  BC071 
  BC054  BC032  BC015  BC072 
  BC088  BC033  BC168  BC138 
 
2.2 Microbiological analysis of Candida albicans species 
 
2.2.1 Culture and identification 
 
Isolates  were  sub cultured  onto  Sabouraud’s  dextrose  agar  plates  (SAB  [Life 
Technologies, UK]). These were incubated for 24 h at 37ºC. The identity of Candida 
species was validated by use of the API ID 32C (bioMérieux UK Ltd, Basingstoke) 
yeast identification system, a standard biochemical system for the identification of 
yeasts. A suspension of each isolate was prepared to a McFarland standard of 2 in 
sterile  saline,  which  was  then  dispensed  into  each  cupule  consisting  of  various 
dehydrated  carbohydrate  substrates.  The  strip  of  cupules  was  then  sealed  to 
prevent evaporation and incubated at 30ºC for 48 h. Based on the microorganisms 
ability to ferment or utilise different substrates a 10 digit numerical profile was 
generated  that  could  be  inputted  in  to  the  Apiweb™  identification  software 
(bioMérieux  UK  Ltd,  Basingstoke),  to  inform  of  the  likely  species  identity 
(https://apiweb.biomerieux.com/). Following confirmation of the isolates identity, 
strains were assessed for their ability to form biofilms.  
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2.2.2 Biofilm formation 
 
A  single  colony  of  each  isolate  was  taken  from  the  appropriate  SAB  plates  and 
inoculated into 10 mL of yeast peptone dextrose (YPD [Sigma Aldrich, UK]) within a 
50 mL centrifuge tube (BD Falcon™). The isolates were grown in an orbital incubator 
at 30ºC overnight at 200 rpm. Cells were then washed by centrifugation at 2000 rpm 
for 5 min, the resulting pellet re suspended in sterile PBS, and cells counted in a 
Naeuber haemocytometer. These were then standardized to 1  x 10
6 cells/mL in 
RPMI  (Roswell  Park  Memorial  Institute)  1640  growth  media  (Sigma Aldrich,  UK). 
Biofilms  were  subsequently  grown  by  dispensing  500   L  and  200   L  of  the 
standardized  solution  to  24  and  96  well  flat bottomed  microtitre  plates, 
respectively (Corning Life Science, UK). Biofilms were then incubated overnight at 
37ºC.  Following biofilm formation, culture media was removed, biofilms washed 
with sterile PBS to remove non adherent cells, and the biomass quantified using a 
crystal  violet  assay.  Biofilms  were  grown  for  periods  of  4  h  (early)  and  24  h 
(mature). 
 
2.2.2.1 Quantification of biofilm formation 
 
Biofilm biomass (Section 3.1.3) was assessed using a modified version of a protocol 
first  developed  by  Christensen  et  al,  and  later  modified  by  Kolter  and  O’Toole 
(Christensen et al., 1985; O'Toole & Kolter, 1998). For each biofilm formed under 
specified  conditions,  spent  culture  media  was  removed  and  the  biofilm  washed 
three times with PBS.  Suitable negative control wells containing no fungi were 
included within each microtitre plate. Biofilms were air dried and 100  L of 0.5% 
w/v crystal violet solution (Fisher Scientific) added for 5 min to permit sufficient 
staining. The solution was removed by carefully rinsing the biofilms under running 
water, until all unbound stain was removed. Biofilms were de stained by adding 100 
 L  of  95%  (v/v)  ethanol  into  each  well.  The  ethanol  was  gently  pipetted  to 
completely solubilise the crystal violet, and the ethanol transferred to a clean 96 
well microtitre plate and absorbance read at 570 nm in a plate reader (FLUOstar 
Omega). A minimum of eight replicate wells were used for each test condition and   30 
results are given as an average of the absorbance and adjusted to account for any 
absorbance due to CV using the negative control well readings. 
 
2.3 Antifungal susceptibility testing  
 
2.3.1 Denture hygiene and ‘gold standard’ denture care products 
 
Polident®  denture  cleanser  and  a  novel  formulation  of  this  denture  cleanser; 
Polident® partials (courtesy of GlaxoSmithKline, Parsippany, NJ, USA) were used in 
this  study  alongside  Colgate®  cavity  protection  toothpaste  (Colgate®  Palmolive, 
USA).  ‘Gold  standard’  denture  care  products;  Milton®  sterilising  tablets  and 
Corsodyl  were  also  assessed  for  biofilm  inhibition  properties  (Section  3.1.4). 
Concentrations used are listed in Table 2.2 alongside novel antifungal compounds 
tested  (Section  2.6).  Antifungals  were  prepared  according  to  manufacturer’s 
instructions or prior optimisation studies. 
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Table 2.2 Quantity/concentrations of antifungals used in studies.  
 
Compound  Active Ingredients  Manufacturer  Instructions 
Polident® (pH 
7.0) 
GlaxoSmithKline, 
Parsippany, NJ, USA 
Dissolve 1 tablet in 100 mL of 
distilled  water  and  use  at 
40ºC  
Improved 
Polident® 
formulation (pH 
8.6) 
Sodium bicarborbonate, 
citric acid, sodium 
carbonate, potassium 
caroate, sodium 
perborate, TAED, 
sodium benzoate, PEG 
180, sodium lauryl 
sulfoacetate 
GlaxoSmithKline, 
Parsippany, NJ, USA 
Dissolve 1 tablet in 100 mL of 
distilled water and use at 
40ºC  
Colgate® cavity 
protection 
toothpaste  
Sodium 
monofluorophosphate 
(0.15% w/v fluoride ion) 
Colgate Palmolive, 
Guilford, Surrey, UK 
Prepare a 10:90% (w/v) slurry 
in  sterile  distilled  water  at 
room temperature 
Milton® sterilising 
tablets  
Sodium 
dichloroisocyanurate 
(19.5% m/m) 
Cueta Healthcare Ltd, 
Bournemouth, Dorset, 
UK 
Dissolve  1  tablet  in  5  L  of 
distilled water 
Corsodyl 
0.2% w/v chlorhexidine 
digluconate, 7% v/v 
ethanol 
GlaxoSmithKline, 
Brentford, Middlesex, 
UK 
Dilute  to  working 
concentration with RPMI 
Farnesol   N/A 
Sigma, Gillingham, 
Dorset, UK 
Working solutions of 600, 300 
and 150  M in RPMI  
EDTA   N/A 
Sigma, Gillingham, 
Dorset, UK 
Working solutions of 500, 250 
and 125 mM in RPMI  
 
 
 
 
 
 
 
   32 
2.3.2 Candida albicans biofilm inhibition by treatment with Milton® sterilising 
tablets and Corsodyl 
 
Early and mature biofilms of 4 NT strains were grown in triplicate in a 96 well 
microtitre plate as previously described. Excess media was removed and 100  L 
neat solutions of Milton® sterilising tablets and 0.2% Corsodyl (Table 2.2) were used 
to treat biofilms for 3 min and 24 h. Solutions were subsequently removed, biofilms 
washed  briefly  with  sterile  PBS  and  an  XTT  assay  performed  to  assess  biofilm 
viability following treatment (as described in Section 2.3.4) 
 
2.3.3 CLSI broth microdilution susceptibility testing 
 
Antifungal  testing  (Section  3.3.2)  to  determine  the  minimal  inhibitory 
concentrations  (MIC)  of  defined  compounds  in  planktonic  C.  albicans  cells  was 
performed  using  the  Clinical  Laboratory  Standards  Institute  M27 A3  broth 
microdilution method for yeasts (CLSI, 2008). All preparations for microtitre plates 
were performed in a Microflow laminar flow biological safety cabinet (Bioquell UK 
Limited, Andover, Hants, UK). 100  L aliquots of RPMI were dispensed into columns 
2  to  10  in  a  96 well  microtitre  plates  (round bottomed  wells).  200   L  of  each 
compound was dispensed into column 1 and then serially double diluted to give a 
final concentration range of 50% to 0.098% for Polident® and Polident® partials in 
columns 1 to 10 after the addition of yeast suspensions. Column 11 served as a 
positive control (no compound), and column 12 served as a negative control (media 
only). Because of the opacity of Colgate® dentrifice, then MIC testing could not be 
performed based on the visual reading of the test. 
 
Each clinical strain was propagated on SAB agar overnight at 30
oC. A loopful of 
culture was removed and a yeast suspension prepared in sterile phosphate buffered 
saline (PBS: 10 mM phosphate buffer, 2.7 mM potassium chloride, 137 mM sodium 
chloride, pH 7.4 [Oxoid, Cambridge, UK]). This suspension was further diluted 1:10 
in PBS to enable enumeration of cells/ml in a Neubauer haemocytometer (Fisher 
Scientific, UK). Each strain was subsequently adjusted to a density of 10
4 cells/mL 
in RPMI 1640. 100  L of cellular suspension was added to microtitre wells
 containing   33 
defined compounds, including the antifungal free positive control. The microtitre 
plates were then incubated at 37
oC for 24 to 48 h. The MIC was determined by 
directly  visualising  yeast  growth  within  the  microtitre  plate  and  selecting  the 
lowest concentration of each derivative that inhibited growth of the test isolate, 
compared to positive control.   
 
2.3.4 Sessile susceptibility testing 
 
Antifungal  susceptibility  testing  of  sessile  cells  was  performed  as  previously 
reported (Ramage et al., 2001a). Isolates were propagated from a loopful of cells 
from SAB agar plates and inoculated into 10 mL of yeast peptone dextrose broth 
(YPD [Oxoid, UK]). These were incubated at 30
oC overnight in an orbital shaker at 
400 rpm (Vortemp1550, Labnet International Inc, Woodbridge, NJ, USA). All strains 
grew in the budding–yeast phase. Cells were centrifuged at 3000 rpm for 10 min, 
and  the  pellet  resuspended  in  5  mL  PBS.  This  was  diluted  1:100  in  PBS  and 
enumerated as described above. All isolates were adjusted to 1 × 10
6 cells/ml in 
RPMI  1640.  Biofilms  were  formed  on  commercially  available  pre sterilised, 
polystyrene, flat bottomed, 96 well microtitre plates (Corning, Sigma Aldrich, UK) 
by pipetting standardised cell suspensions (200 ml of the 1 ´ 10
6 cells/mL) into each 
well of the microtitre plate (final inoculum of 2 × 10
5 cells/well) and incubating for 
24  h  at  37
oC.  Following  biofilm  growth,  media  was  removed  and  antifungal 
components  serially  double diluted  to  give  a  final  concentration  range  of  50% 
0.098% for Polident®, Polident® partials and Colgate®  within the microtitre plate. 
These were incubated at 37
oC for 24 h. Antifungal free wells and biofilm free wells 
served as positive and negative controls, respectively. Sessile minimal fungicidal 
concentrations (SMFC50 and SMFC80) were determined as the lowest concentration of 
antifungal giving a 50% or 80% reduction in biofilm metabolic activity relative to the 
antifungal free control, using the XTT reduction assay, as described below (Pierce 
et al., 2008; Ramage et al., 2001a; Ramage & Lopez Ribot, 2005). Testing of these 
isolates was performed in duplicate.  
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2.3.5 2,3 bis(2 methoxy 4 nitro 5 sulfo phenyl) 2H tetrazolium 5 carboxanilide 
(XTT) reduction assay 
 
A  semi quantitative  measure  of  biofilm  formation  was  calculated  using  an  XTT 
reduction assay, adapted from previous studies (Pierce et al., 2008). Briefly, XTT 
(Sigma Aldrich) was prepared in a saturated solution at 0.5 g/L in PBS. The solution 
was filter sterilised through 22  m pore size filter, aliquoted, and stored at  80
oC. 
Prior to each assay, an aliquot of stock XTT was thawed, and menadione (Sigma 
Aldrich, 10 mM prepared in acetone) added to a final concentration of 10  M. A 100 
 L aliquot of XTT/menadione solution was then added to each pre washed biofilm, 
and to negative control wells containing no C. albicans to measure background XTT 
reduction levels. The plates were then incubated in the dark for 3 h at 37
oC and 
colour  change  measured  using  a  microtitre  plate  reader  (FluoStar  Optima,  BMG 
Labtech, Basingstoke, UK) at 490 nm. A minimum of eight replicate wells were used 
for each test condition and absorbance results averaged and adjusted to correct for 
any absorbance of XTT/menadione using the negative control well readings. The 
colorimetric  change  in  the  XTT reduction  assay  directly  correlates  with  the 
metabolic activity of the biofilm as previously described (Ramage et al., 2001a).   
 
2.3.6 Time kill kinetics 
 
C. albicans killing efficacy of the two Polident® denture cleansers and Colgate® 
toothpaste  (described  fully  in  Section  2.4)  was  assessed  over  a  set  time  period 
(Section 3.3.5). Initially overnight biofilms of the 4 NT strains were grown in 96 well 
microtitre plates as described previously. Excess media was discarded and 100  L of 
each of the above solutions (Table 2.1) were allowed to interact with biofilms for 
time points of 30 s, 1 min, 3 min, 5 min and 10 min. Solutions were subsequently 
removed and biofilms washed briefly with sterile PBS. An XTT assay was conducted 
to assess biofilm viability following treatment. 
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2.4  Treatment  of  Candida  albicans  biofilm  with  Polident®  denture  cleansers 
and Colgate® toothpaste 
 
Results are described in Section 3.3. Two commercially available denture cleansers 
with different optimal pH’s of 7.0 and 8.6 (Polident®, GlaxoSmithKline, USA) and a 
commercially available toothpaste (Colgate Cavity Protection Toothpaste, Colgate® 
Palmolive,  USA)  were  used  throughout  the  study.  Each  C.  albicans  isolate  were 
inoculated onto 1 cm
2 acrylic resin sections within a 24 well tissue culture plate 
(Costar®, Corning Inc, MA, USA) at an optimised concentration of 1 x 10
6 cells/mL 
in RPMI for 4 h at 37ºC, as previously described (Ramage et al., 2001b),  prior to a 
series of treatment regimens. These sections were initially treated after 4 h with 
the denture cleansers and sequentially thereafter at 24, 48 and 72 h. Each 1 cm
2 
section  was  treated  by  immersing  in  denture  cleanser  solution  for  3  min  using 
sterile forceps, which were removed and gently washed in sterile PBS to remove 
excess denture cleanser solution. Following treatment, sections were transferred to 
bijou tubes (Sterilin Ltd, UK) containing 1 mL of sterile PBS, and sonicated at 35 
kHz for 5 min (Ultrasonic bath [Fisherbrand, Fisher Scientific, UK]). Total viable 
counts  were  then quantified  using  the  Miles  and  Misra  plate  counting  technique 
onto SAB agar plates. In parallel, total viable counts were quantified on sections 
with no treatment at each time point (control) and  on sections treated and re 
incubated in RPMI at 37
oC overnight prior to the next treatment phase to assess 
regrowth.  All  experiments  were  performed  on  all  strains  at  least  two  separate 
occasions and in triplicate. 
Intermittent studies were also performed to assess how brushing with toothpaste 
impacted denture cleansing. These experiments were identical to those described 
above, but at 24 h and 48 h the sections were brushed with a 10% w/v slurry of 
toothpaste (25
oC) in ddH2O for approximately 2 s using a soft bristle toothbrush 
(Oral B ®, Proctor and Gamble, USA). The 2 s time was calculated based on the 
proportional surface area of an upper denture being brushed for an average of 2 
min. All sections were processed as described above, including appropriate controls.  
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2.4.1 Visualisation of treated biofilms by scanning electron microscopy (SEM) 
 
An  early  C.  albicans  (NT3)  biofilm  was  grown  on  denture  material  sections 
(GlaxoSmithKline, USA). Biofilms either remained untreated or were treated with 
Polident®, Polident® followed by brushing with toothbrush, Polident® partials or 
Colgate®  followed  by  brushing,  as  described  above.  Preparation  for  SEM  was 
conducted as previously outlined (Erlandsen et al., 2004).  Following treatment, 
sections were transferred to 24 well plates and covered with 500  L of fixative (2% 
v/v para formaldehyde, 2% v/v gluteraldehyde, 0.15M sodium cacodylate and 0.15% 
w/v Alcian Blue).  Sections were fixed for 2 h, fixative removed and sections rinsed 
in  0.15M  sodium  cacodylate  ready  for  processing.  Sections  were  then  rinsed  a 
further three times for 5 min with sodium cacodylate. Following this, sections were 
incubated in 1% osmium tetroxide for 1 h and washed three times for 10 min in 
distilled water. Sections were then incubated in uranyl aceytate aqueous solution in 
the dark for 1 h following by a series of dehydration steps in alcohol: 30%, 50%, 70%, 
90% and absolute alcohol for 10 min/alcohol, excluding absolute alcohol in which 
sections  remained  for  2  x  10  min.  Sections  were  dried  twice  for  5  min  in 
hexamethyldisilazane (HMDS) in a dessicator before mounting on aluminium stubs 
with double sided copper tape. Samples were covered by painting with silver paint, 
using fine brush to increase conductivity. Finally, sections were covered by gold 
sputter coating and viewed using a JEOL JSM 6400 scanning electron microscope.  
 
2.5 Manufacture of denture material sections 
 
Bespoke  denture  material  sections  were  manufactured  for  use  in  cell  culture 
studies.  There  was  a  requirement  for  thin  (<  0.5  mm)  sections  for  use  in  the 
epithelial cell/biofilm model outlined in Figure 2.3. All other studies employed the 
1cm
2 denture material sections provided by GlaxoSmithKline. 
 
The mould for the formation of denture material sections was formed using a 1 mm 
thick PETG polyethyleneterephthalate – glycol modified/ Ethylene 1, 4 cycloexylene   37 
terepthalate copolymer disc.   The disc dimension was cut to 5 cm
2 and scored into 
10 mm x 10 mm squares approximately 0.5 mm deep (5 x 5 or 25 sections).     
 
2.5.1 Formation of dental stone 
 
The mould was made using a two part denture flask. Dental stone (Super yellow, 
John Winter & Co Ltd, UK) was mixed with water to a ratio of 100 g powder to 20mL 
water and vacuum mixed to avoid air entrapment in the mixture. The stone mix was 
placed into the shallow half of the denture flask and the PETG disk placed onto this 
having  previously  been  covered  with  a  wetted  film  of  the  dental  stone  mix  as 
demonstrated in Figure 2.1. The mix was allowed to set. A separating medium (50% 
Sodium Silicate solution) was added to the set dental stone surface and rinsed off.  
The mould was completed by filling the second part of the flask with a second 
dental stone mixture spread on top of the PETG sheet, followed by the flask being 
positioned in place with the remainder of the dental stone mix poured to fill the 
mould through the top of the flask. During this process the denture flask was placed 
on a vibrating platform to ensure any air bubbles were removed from the surface of 
the PETG sheet. The dental stone was allowed to set for 1 h. 
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Figure 2.1 PETG sheet placed in dental stone mix to create mould.  
 
2.5.2 Preparation of denture acrylics 
 
The  PMMA  acrylic  was  mixed  according  to  manufacturer’s  instructions.  24  g  of 
power was added to 10 mL of denture base liquid (Chaperlin & Jacobs Ltd, UK) and 
thoroughly mixed together for 30 s then left for approximately 10 min until a snap 
dough texture was achieved. To facilitate opening, the denture flask containing the 
mould was immersed in boiling water for 10 min. Following opening of the flask; the 
PETG disc was removed and the mould cleaned with water and detergent to remove 
any possible greasy residue which would prevent the mould being coated with a 
sealant. A mould seal isolating liquid (Metrodent, UK) was painted on the surface of 
the mould halves and allowed to dry. The acrylic dough was placed on one half of 
the mould and pressed by hand. A cellophane sheet was placed on top of the dough 
and the flask lid (second half of the mould) secured on top. 
 
The flask mould containing the acrylic was then compressed in a hydraulic press at 
100 bar pressure which allowed the excess acrylic to escape from the sides. The 
flask was opened and the cellophane sheet removed before a final closure of the 
flask as observed in Figure 2.2. The flask was placed into a spring compress to 
maintain a continual pressure during the processing procedure.   39 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Packing of PMMA acrylic. 
 
The  compress  was  placed  in  a  dry  heat  bath  for  9  h  in  accordance  with  the 
manufacturer’s instructions (initially the temperature is taken up to 70ºC over a 
seven  hour  period).  The  temperature  was  then  increased  to  100ºC  and  this 
temperature is maintained for 3 h to ensure removal of any residual monomer. 
Following polymerisation and cooling of the flask to room temperature, the flask 
was removed from the compress and opened. The processed acrylic disc was cut 
into 1 cm sections and filed to ensure a smooth finish. 
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2.6 Novel antimicrobial compounds 
 
Results described in Section 3.4. Due to ineffective denture care products; non oral 
hygiene  compounds  were  tested  for  fungal  inhibition.  These  included  EDTA;  a 
cation chelator which has previously been documented as having an effect on C. 
albicans  morphology  from  yeast  to  hyphal  structure  (Ramage  et  al.,  2007)  and 
farnesol; a quorum sensing molecule associated with the yeast morphotype of C. 
albicans (Ramage et al., 2002b).  
 
2.6.1 Candida albicans biofilm treatment with Farnesol and EDTA 
 
Mature  C.  albicans  biofilms  of  4  NT  strains  were  grown  in  triplicate  in  96  well 
microtitre plates as previously described. Excess media was removed and 100  L of 
each solution at decreasing doubling concentrations (Farnesol at 600 150  M and 
EDTA at 500 125 mM). Polident® denture cleanser at 100 25% was also used as a 
direct  comparison  to  treat  biofilms.  Following  a  4  h  treatment,  solutions  were 
removed and biofilms washed with repeatedly with sterile PBS. An XTT assay was 
conducted to assess strain viability following treatment. 
 
2.6.2 Inhibition of Candida albicans by pre coating of substrates with antimicrobials 
 
96 well microtitre plates and PMMA denture material sections were coated with 100 
 L of farnesol, EDTA and Polident®. Antimicrobials were allowed to evaporate from 
surfaces  over  a  24  h  period.  Subsequently,  mature  biofilms  of  NT  strains  were 
grown in triplicate in 96 well microtitre plates as well as on PMMA denture material 
sections  coated  with  antimicrobials  as  previously  described.  A  positive  control 
consisted  of  mature  NT  III  biofilms  grown  without  prior  pre coating.  To  assess 
biofilm viability following treatment of surface compared to positive control; an 
XTT assay was conducted in 96 well microtitre plates and a colony forming unit 
count  was  conducted  following  ultra  sonication  of  denture  material  sections 
containing biofilms as described in section 2.3.7.   
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Biofilm formation following coating of 96 well microtitre plates with antifungal 
substrates was also assessed through utilisation of the crystal violet staining method 
described in section 2.2.2.1. Briefly, mature biofilms were air dried and stained 
with 0.5% w/v crystal violet solution, rinsed under running water and de stained 
with 95% ethanol. Absorbance was read at 570 nm. 
 
2.7 Cell Culture 
 
Described in Section 3.5. Epithelial cells (OKF6 /TERT2) were grown as adherent 
monolayers in 5% CO2, 37
oC. All culture media and supplements were obtained from 
Invitrogen, UK. 
 
2.7.1 OKF6/TERT2 immortalised oral epithelial cell line 
 
OKF6/TERT2 cells were provided by Rheinwald laboratory (Brigham and Woman’s 
Hospital,  Boston).  This  keratinocyte  cell  line  was  immortalised  through  forced 
expression of telomerase. OKF6/TERT2 cells have been shown to resemble primary 
oral keratinocytes in cytokine induction and toxicity studies (Dongari Bagtzoglou & 
Kashleva, 2003). Cells were cultured in keratinocyte serum free medium (K SFM, 
[10725  Invitrogen,  UK]),  supplemented  with  10,000  units  penicillin  and  10  mg 
streptomycin per mL in 0.9% NaCl, 25 mg/ mL bovine pituitary extract (BPE), 0.2 
ng/ mL epidermal growth factor (EGF) and 0.2 mM CaCl2 (0.4 mM total Ca
++). BPE 
and EGF were filter sterilised through 0.2  m filter pore. Cells were seeded at 1 x 
10
5/mL in a 75 cm
2 flask (Corning Life Sciences, NY). Cells were allowed to reach 
90 100%  confluence  before  passage.  This  was  achieved  by  removing  K SFM  and 
washing cells with 10 mL of PBS (D8662, Sigma Aldrich, UK). 5mL 0.05% trypsin + 
EDTA  solution  (13924,  Sigma Aldrich,  UK) was  added  to  detach  cells  from  flask. 
Trypsin  was  allowed  to  act  for  ~  5  min  and  cells  were  observed  under  light 
microscopy to ensure full detachment. The trypsin was neutralised by addition of 15 
mL of Dulbecco’s Modified Eagle Medium [(DMEM, D8662 Sigma Aldrich, UK)] and 
centrifuged for 5 min at 1000 rpm. The resulting cell pellet was resuspended in 10 
mL Hank’s Balanced Salt Solution (H9269, Sigma Aldrich, UK) and centrifuged as 
above. The resulting pellet was resuspended in K SFM and live cells counted by   42 
staining with trypan blue solution (0.4%) (Sigma Aldrich, UK). To assess cytokine 
responses cells were seeded in a total of 1.5 mL at a density of 1 x 10
5 cells of 
defined keratinocyte free medium (DK SFM, 10785 [Invitrogen, UK]) in a 24 well 
culture plate. This media contained 0.2 mM CaCl2 (0.4 mM total Ca
++) and DKSFM 
growth supplement (10784, Invitrogen, UK). 
 
2.7.1.1 Stimulation of OKF6/TERT2 cells 
 
To  assess  the  response  of  OKF6/TERT2  cells  to  various  stimulants,  IL 8  protein 
release was quantified using ELISA technology. Studies were designed to assess the 
effect of both planktonic and sessile C. albicans on IL 8 release, and how antifungal 
treatment impacted upon this. C. albicans strain BC071 (NT3) was used for all these 
experiments. OKF6/TERT2 cells were grown in 24 well plates at 1 x 10
5 cells/mL 
until 90 100% confluent. These were then stimulated with planktonic C. albicans at 
concentrations of 1 x 10
5 and 1 x 10
6 cells/mL. Treatment of planktonic C. albicans 
cells consisted of cells being initially centrifuged at 3000 rpm for 10 min, and the 
pellet resuspended in 1 mL of neat Polident ® for 3 min. Cells were washed with 
sterile PBS and centrifuged to remove excess denture cleanser. This process was 
repeated in triplicate.  Resulting cells were used for OKF6/TERT cell stimulations. 
Early  (4  h)  and  mature  (24  h)  biofilms  were  grown  on  manufactured  denture 
material sections, as described above (see section 2.3).  Biofilms were treated with 
Polident ® by immersion of denture material sections containing early and mature 
biofilms in denture cleanser for 3 min. Sections were then repeatedly dipped in 
sterile  PBS  to  remove  excess  denture  cleanser.  Sections  containing  treated  and 
untreated biofilms were attached to hanging inserts with sterile Vaseline® as shown 
in Figure 2.3. Inserts were then placed into wells containing epithelial cells. This 
model allowed a 0.5 mm gap between the biofilm and the cells and avoided direct 
media starvation of the epithelial cells.   
 
Zymosan A (zym) from S. cerevisiae cell wall was used as a positive control for IL 8 
release.  OKF6/TERT2 cells were stimulated for 4 and 24 h in 5% CO2 at 37
oC. Cell 
supernatants were then removed and used to perform IL 8 ELISAs while OKF6/TERT 
cells were used for gene expression analysis.   43 
 
 
Figure 2.3 In vitro model of Candida biofilm interaction with epithelial cell layer.  
 
2.7.1.2 Analysis of gene expression 
 
OKF6/TERT2  gene  expression  was  measured  through  quantitative  reverse 
transcription polymerase chain reaction (QRT PCR). This method allowed rapid and 
specific identification of up/down regulation of IL 8 gene expression in response to 
the previously stated stimulants. 
 
2.7.1.2.1 RNA extraction, quantification and DNA synthesis 
 
Following the removal of cell supernatants, RNA was extracted from OKF6/TERT2 
cells  through  the  use  of  the  RNeasy  mini  kit  (Qiagen,  UK),  according  to 
manufacturer’s instructions. The RNA obtained was quantified using the NanoDrop 
1000 Spectrophotometer (Thermo Scientific). 1.5  L of RNA from each sample was 
loaded  onto  NanoDrop  pedestal.  The  resultant  RNA  was  of  high  quality, 
approximating  2.0  (260/280).  cDNA  synthesis  was  achieved  using  SuperScript®  II 
Reverse Transcriptase (Invitrogen, UK). 
 
2.7.1.2.2 Real time quantitative PCR 
 
Expression  levels  of  IL 8  were  measured  in  relation  to  the  house  keeping  gene 
glyceraldehydes 3 phosphate  dehydrogenase  (GAPDH).  The  thermal  profile  was 
optimised for primers used (Tables 2.3 and 2.4). Each well contained 12.5  L of 
Hanging insert 
Biofilm on acrylic section 
Epithelial cells on well bottom 
Cell culture media   44 
SYBR green master mix (Invitrogen, UK), 0.5  L of forward and 0.5  L of reverse 
primers, 2  L of cDNA and 9.5  L of DNase/RNase free water (Qiagen, UK) to make 
up a total volume of 25  L. 
 
The mean efficiencies were determined in the sample triplicates and used to adjust 
the  cycle  threshold  (Ct)  values.  Ct  values  were  used  for  the  quantitative 
comparison  of  the  amplification  rates.  After  baseline  subtraction,  the  mean  Ct 
values of the triplicates were determined and transformed into relative quantities.              
 
Table 2.3 Primers used in the study. A) Primers were chosen in line with previous 
literature. B) Primer conditions; including temperature and number of cycles. 
 
A) 
Target   Primer  Reference 
IL 8 Forward  TTAGCACTCCTTGGCAAAAC 
IL 8 Reverse  CAGAGACAGCAGAGCACACAA 
 
(Li et al., 2007a) 
 
GAPDH Inner 1  CAAGGCTGAGAACGGGAAG 
GAPDH Inner 2  GGTGGTGAAGACGCCAGT 
 
(McKimmie et al., 2008) 
 
B) 
Function  Temperature (
ºC)  Time  Cycles 
Denaturation  55  2 min  1 
Denaturation 
Annealing 
Extension 
95 
95 
59 
10 min 
30 s 
1 min 
 
40 
Extension  72  1 min  1 
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2.7.1.3 IL-8 Cytokine Assay 
 
ELISA  kits  (BioSource,  Invitrogen,  UK)  were  used  in  accordance  with  the 
manufacturer’s instructions. Buffers used are listed in Table 2.5. All assays were 
optimised  and  validated  prior  to  use.  An  Immulon  4  HBX  flat bottom  96 well 
microtitre plate (Fisher Scientific, UK) was coated with coating buffer, sealed and 
incubated overnight at 4ºC.  Between steps, the plate was washed 5 times with 
wash buffer to remove reagents and unbound antibody. 100  L of standards ranging 
from 2000 31.25 pg/mL and samples of cell supernatants were added to wells in 
duplicate  or  triplicate.  The  final  colour  change  from  clear  to  bright  blue  was 
measured after the addition of TMB substrate at an absorbance of 450 nm (FLUOstar 
Omega, BMG LabTech). The results were calculated using a 4 parameter curve fit. 
 
Table 2.4: Buffers used for IL-8 ELISA.  
 
Coating Buffer  0.1 M NaHCO3 (pH 8.2) 
Assay Buffer  5 g BSA and 1 mL Tween 20/1L PBS (pH 7.4) 
Wash Buffer  500  L Tween 20/1L PBS (pH 7.4) 
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3. Results 
 
3.1 Phenotypic characterisation of NT strains 
 
3.1.1 Introduction 
 
An important characteristic of the opportunistic pathogen C. albicans is its ability 
to  exist  in  both  yeast  and  hyphae  forms.  These  are  both  important  in  the 
development and maintenance of biofilm consortia (Bachmann et al., 2003). Biofilm 
formation  of  C.  albicans  strains  is  associated  with  the  ability  to  successfully 
colonise  surfaces  and  resist  removal  through  chemical  and  physical  cleansing 
(Ramage et al., 2004). Other pathogenic traits of the species include the production 
of  degradative  enzymes,  which  are  associated  with  virulence.  A  correlation 
between  the  production  of  these  enzymes  and  biofilm  formation  by  C.  albicans 
strains has been recently demonstrated (Rajendran et al., 2010). 
 
The aim of this component of the study was to characterise the biofilm properties 
of  C.  albicans  clinical  strains  isolated  from  denture  stomatitis  patients.  This 
included  biofilm  formation  and  their  sensitivity  to  commonly  used  antimicrobial 
agents  used  to  control  oral  candidosis  and  disinfect  dentures.  Four  strains 
representing each of Newton’s Type’s of inflammation of the palate (BC052 [0], 
BC030  [I],  BC015  [II]  and  BC071  [III])  were  used  for  these  studies,  including  an 
American Type Culture Collection strain (ATCC 90028) as a positive biofilm control.   
 
3.1.2 Planktonic growth 
 
Growth  rates  of  planktonic  cells  were  assessed  in  order  to  demonstrate  that 
potential  differences  in  biofilm  formation  or  sensitivity  were  not  related  to 
restricted growth kinetics, and could therefore be  compared equally. All strains 
reached  exponential  and  lag  phase  at  a  similar  rate  (Figure  3.1).  Rates  of 
exponential growth were as follows: 0.33 O.D/h (ATCC 90028), 0.36 O.D/h (BC052), 
0.41 O.D/h (BC030) and 0.48 O.D/h (BC015 and BC071).  NT I strain BC030 was 
shown to reach exponential phase at the quickest rate after approximately 5 h.   48 
 
 
 
Figure 3.1: Planktonic Candida albicans NT strains grow at comparable rates. NT 
strains BC052 (0), BC030 (I), BC015 (II) and BC071 (III) and type strain ATCC90028 
were grown in planktonic form for 20 h in a round bottomed 96 well microtitre 
plate in RPMI from an initial concentration of 1 x 10
4 cells/mL.  
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3.1.3 Biofilm formation 
 
3.1.3.1 Assessment of biofilm biomass 
 
Biofilm formation was shown to vary between strains as illustrated in Figure 3.2. NT 
strains  0,  II  and  III  formed  stable  biofilms  covering  the  well  (Figure  3.2B). 
Statistically poorer biofilm formation was observed with NT strain I compared to 
ATCC90028 (p < 0.05). 
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Figure  3.2:  The  biofilm  forming  ability  of  Candida  albicans  NT  biofilms  is 
variable A) Absorbance readings of biofilm biomass. B) Visual representation of NT 
strain  biofilms.  Biofilms  were  formed  in  microtitre  plates  by  standardisation  of 
planktonic  cells  to  a  concentration  of  1  x  10
6  cells/mL  in  RPMI  and  subsequent 
incubation at 37ºC overnight. Biofilms were dried, stained with 0.5% w/v crystal 
violet, washed and de stained with 100% ethanol. Absorbance was measured at 570 
nm. 
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3.1.3.2 Assessment of Candida albicans metabolism 
 
Assessment  of  biomass  does  not  provide  an  indication  of  C.  albicans  viability. 
Therefore,  biofilm  viability  studies  (Section  2.3.5  2)  were  performed  to  assess 
whether  there  was  a  variation  in  metabolic  activity  in  NT  biofilms.  Metabolic 
activity of mature biofilms formed by different NT strains was assessed using the 
XTT  assay  (Figure  3.3).  A  significantly  lower  (p=  <  0.01)  C.  albicans  metabolic 
activity was observed for NT strains 1 and 3 compared to control strain ATCC90028.  
Variation in biofilm metabolism was observed independent of biofilm biomass. This 
suggests that metabolic assays do not necessarily reflect good biofilm formation.  
 
Following the variation of C. albicans metabolism observed in Figure 3.3 a study 
was designed to determine the sensitivity of the XTT assay to C. albicans viability 
(Figure  3.4).  Depending  on  sensitivity  levels,  this  assay  would  then  be  further 
utilised  for  investigations  relating  to  treatment  of  C.  albicans  cells  with 
antimicrobial  compounds.  Metabolic  activity  of  NT  C.  albicans  planktonic  cells 
ranging from 1 x 10
1 – 1 x 10
8 cells/mL was quantified. Linear regression analysis 
indicated  that  there was  a  positive  correlation  between  cell  concentrations  and 
absorbance  (R
2=  0.8133).  The  assay  did  not  detect  cell  concentrations  <1  x  10
5 
cells/mL.    These  results  present  implications  for  future  viability  assays  as  C. 
albicans cell numbers of < 1 x 10
5 cells/mL cannot be detected.  
   52 
 
Figure 3.3: The metabolic activity of Candida albicans NT biofilms is variable. 
Biofilms were formed in microtitre plates by standardisation of planktonic cells to a 
concentration  of  1  x  10
6  cells/mL  in  RPMI  and  subsequent  incubation  at  37  ºC 
overnight. The XTT assay was performed and absorbance measured at 492 nm.  
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Figure  3.4:  The  XTT  assay  has  a  dynamic  but  limited  sensitivity  to  Candida 
albicans metabolism. C. albicans planktonic cells were serial diluted in PBS to give 
a concentration range of 1 x 10
1 – 1 x 10
8 cells/mL. Cells were centrifuged and 
pellets re suspended in XTT.  Following a 3 h incubation at 37ºC, absorbance was 
measured at 492 nm.  
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3.1.4 Rapid in vitro assessment of ‘gold standard’ denture care products against 
Candida albicans biofilms  
 
3.1.4.1 Introduction 
 
Lasting  treatment  of  denture  stomatitis  often  requires  a  number  of  factors, 
including  establishment  of  an  appropriate  oral  hygiene  regimen  as  well  as  daily 
treatment of dentures to reduce the possibility of re establishment of infection. 
‘Gold  standard’  treatments  recommended  by  dental  practitioners  for  the 
decontamination  of  dentures  include  soaking  dentures  in  solutions  containing 
chlorhexidine (Pusateri et al., 2009b; Redding et al., 2009) or Milton® sanitizer 
(Clarkson et al., 2003). 
 
3.1.4.2 Biofilm treatment with Milton® sterilising tablets and Corsodyl  
 
These  studies  aimed  to  assess  biofilm  inhibition  through  the  use  of  products 
recommended by dental professionals for the treatment of oral candidosis. Milton 
sterilising  tablets  (sodium  dichloroisocyanurate  [19.5%  m/m])  and  Corsodyl 
(chlorhexidine [0.2%]) were used to treat early and mature NT biofilms. 
 
Results  indicate  that  both  Milton®  and  Corsodyl  completely  eradicate  early  and 
mature biofilms after a 24 h treatment. However, a 3 min treatment with both 
products resulted in >90% inhibition of early biofilms (4 h). A disparity in treatment 
efficacy  between  the  two  products  was  observed  following  3  min  treatment  of 
mature biofilms. Corsodyl treatment was significantly (p= 0.0113) more effective 
than treatment with Milton® sterilising tablets at reducing C. albicans viability; 24 
h biofilms were inhibited by >40% and >80% by Milton® and Corsodyl, respectively, 
compared to untreated control. 
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Figure  3.5:  Reduction  in  Candida  albicans  viability  after  treatment  of  NT 
biofilms with Milton® Sterilising Tablets and Corsodyl. Biofilms of NT strains were 
grown for (A) 4 and (B) 24 h in 96 well microtitre plates before treatment with 
Milton® sterilising tablets (sodium dichloroisocyanurate [19.5% m/m]) and Corsodyl 
(chlorhexidine 0.2%) for 3 min and 24 h. 
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3.2 Candida albicans biofilm formation on denture acrylic 
 
3.2.1 Introduction 
 
Long standing evidence indicates that C. albicans adheres to and forms biofilms on 
a  variety  of  surfaces.  These  include  various  medical  devices  as  well  as  oral 
prosthesis (Kojic & Darouiche, 2004; Nevzatoglu et al., 2007). Candidal colonisation 
of  dentures  leads  to  the  onset  of  denture  induced  stomatitis  which  ranges  in 
severity of symptoms (Coco et al., 2008; Ramage et al., 2004).  
 
Since the study of biofilm formation on whole dentures is impractical and inherently 
problematic, it was decided that biofilm investigations were conducted on acrylic 
denture material sections and in 96 well microtitre plates when high throughput 
analysis was required. 
 
3.2.2  Optimisation  of  Candida  albicans  cell  concentration  for  biofilm  growth  on 
denture material 
  
C.  albicans  cell  concentrations  of  1  x  10
6  cells/mL  are  used  throughout  the 
literature as the standard for biofilm formation (Ramage et al., 2001a). However, 
this  is  optimised  for  the  96  well  format  and  may  not  be  applicable  to  denture 
material  studies.  Therefore,  biofilm  formation  of  C.  albicans  on  1  cm
2  denture 
material sections was initially assessed using both 1 x 10
6 and 1 x 10
7 cells/mL, as 
illustrated in Figure 3.6. Due to experimental constraints during optimisation NT III 
strain BC071 was used as it was previously demonstrated that this isolate formed 
stable biofilms (Figure 3.2). 24 h biofilms were grown from both concentrations on 
pre sterilised denture material sections. Although there was a significant difference 
between  biofilm  growth  of  the  two  concentrations  after  24  h  (***p=  0.0022), 
inoculation  of  sections  with  1  x  10
7  cells/mL  of  C.  albicans  resulted  in  an  80% 
decrease in cell concentration from initial inocula while inoculation with 1 x 10
6 
cells/mL resulted in an overall 16% increase in final cell concentration.  Following 
this  result  concentrations  of  1  x  10
6  cells/mL  were  used  for  the  remainder  of 
studies.   57 
 
Figure  3.6:  Optimisation  of  Candida  albicans  cell  concentration  for  biofilm 
formation on denture material. Strain BC071 (III) at concentrations of 1 x 10
6 and 1 
x 10
7 cells/ mL was used to form biofilms on 1 cm
2 denture material sections in 
RPMI at 37
oC. After 24 h, viable C. albicans cells were assessed through sonication 
of  denture  material  sections  and  conducting  colony  forming  unit  counts.  A 
significant  difference  (***p=0.0022)  between  biofilm  growth  of  the  two 
concentrations was observed. Ultimately, an initial inoculum of 1 x 10
6 cells/mL 
resulted in a 16% increase in cell concentration after 24 h compared to an 80% 
decrease in cell concentration following an initial inoculum of 1 x 10
7 cells/mL. 
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3.2.3 Time kinetics of biofilm formation 
 
Growth of NT III strain biofilms on acrylic sections was investigated over a defined 
time  period  (4,  24,  48  h).  The  Miles  and Misra  technique  for conducting  colony 
counts  was  utilised  and  C.  albicans  cell  concentrations/mL  were  calculated  as 
demonstrated in Figure 3.7. Biofilm viability remained moderately constant. Mean 
CFU’s/mL were as follows: 2.88 x10
6, 8.83 x 10
5 and 1.78 x 10
6 cells/mL for each 
time point, respectively (Figure 3.7a). Scanning electron microscopy images taken 
at the above time points indicate an increase in biofilm biomass with time, showing 
a  progression  from  early  hyphae  formation  to  mature  biofilm,  but  this  did  not 
significantly impact the colony counts (Figure 3.7b) 
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i)                                         ii)                                      iii) 
Figure 3.7: Sustained biofilm growth for 48 hours on denture material sections. 
A) Colony forming units of C. albicans from sonicated sections. B) SEM images of 
biofilms on sections after i) 4 ii) 24 and iii) 48 h. Biofilms of strain BC071 (III) were 
grown on denture material sections for a total of 48 h in RPMI at 37
oC. Biofilm 
containing sections were sonicated after 4, 24 and 48 h and colony forming units 
counted. Levels of C. albicans viability on sections remained stable independent of 
time. In contrast SEM images indicate hyphal progression after 4 h which can be 
visualised as a denser biofilm with many yeast and hyphal cells after 24 and 48 h. 
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3.3 Effect of denture cleansers on Candida albicans biofilms 
 
3.3.1 Introduction  
 
Conventional denture cleansing techniques comprise of soaking dentures in an over 
the counter denture cleanser solution or brushing with dentifrice. Recent evidence 
has shown that this second method should not be minimised due to physical damage 
to  dentures  caused  by  brushing,  which  subsequently  facilitates  attachment  of 
Candida species (Charman et al., 2009). In contrast, denture cleansers are highly 
effective in inhibiting C. albicans biofilms, although retention of biofilm biomass on 
the denture surface leads to potential regrowth (Jose et al., 2010). These studies 
were  designed  to  assess  two  commercial  denture  cleansers  in  comparison  to 
brushing  with  commercially  available  dentifrice  to  determine  their  impact  on 
biofilms  and  candidal  retention,  and  to  assess  intermittent  use  of  a  denture 
cleanser with brushing with dentifrice. 
 
3.3.2 Planktonic and sessile minimum inhibition concentration (MIC) 
 
MICs  of  the  two  denture  cleansers  and  dentifrice  were  established  for  both 
planktonic and sessile C. albicans NT strains as well as type strain ATCC 90028 as 
described in Table 3.1. The MIC for planktonic cells did not differ when incubated 
with either of the Polident® denture cleansers. In comparison, the MIC for sessile 
cells  was  decreased  by  one  dilution  from  50%  to  25%  by  treatment  with  novel 
formulation of the Polident® (pH 8.6) denture cleanser. Both Polident® denture 
cleansers were more effective than Colgate® dentifrice against planktonic cells. All 
strains showed equivalent sensitivity under each experimental parameter.  
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Table  3.1  Decrease  in  planktonic  and  sessile  MIC  with  denture  cleansers  in 
comparison  to  dentifrice.  Planktonic and sessile MICs were conducted for 4 NT 
strains  and  type  strain  ATCC  90028  treated  with  two  denture  cleansers  and 
dentifrice  using CLSI and biofilm  sensitivity  testing (Ramage  et  al.,  2001a).  The 
planktonic MIC with both denture cleansers remained the same while the sessile MIC 
was  reduced  from  50%  to  25%  following  treatment  with  Polident®  (pH  8.6).  No 
strain differences were observed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
POLIDENT®  
(pH 7.0) 
POLIDENT®  
(pH 8.6) 
COLGATE® 
Strain 
PMIC  SMIC  PMIC  SMIC  PMIC  SMIC 
ATCC90028 (C)  6.25%  50%  6.25%  25%  25%  50% 
BC052 (NT0)  6.25%  50%  6.25%  25%  25%  50% 
BC030 (NT1)  6.25%  50%  6.25%  25%  25%  50% 
BC015 (NTII)  6.25%  50%  6.25%  25%  25%  50% 
BC071 (NTIII)  6.25%  50%  6.25%  25%  25%  50%   62 
3.3.3 Preliminary assessment of denture cleanser (pH 7.0) and dentifrice treatment 
on Candida albicans biofilms decontamination 
 
Early biofilms (4 h) of all NT strains were formed on pre sterilised denture material 
sections (1 cm
2). These were treated with Polident® (pH 7.0) alone, Polident® (pH 
7.0) followed by brushing with a soft bristle toothbrush, or with dentifrice followed 
by  brushing.  Treatment  after  4  h  biofilm  formation  and  C.  albicans  capacity  to 
regrow  after  24  h  incubation  in  RPMI  was  investigated  by  sonicating  denture 
material  discs,  performing  serial  dilutions  and  subsequently  conducting  colony 
forming  unit  counts,  as  illustrated  in  Figure  3.8a.  Results  indicate  that  early 
biofilms were completely inhibited with both Polident® (pH 7.0) treatments and 
significantly reduced (**p= < 0.01) by treatment with dentifrice and brushing. C. 
albicans colony counts increased in all treatment groups on sections re incubated in 
RPMI after 24 h. SEM images of C. albicans biofilms on PMMA sections following 
outlined treatments (Figure 3.8b) indicated evidence of varying degrees of residual 
biofilm structure after all treatment options.  
 
No significant difference was observed in the Polident® (pH 7.0) treatment groups ± 
brushing, so all further studies were conducted by treating with Polident® (pH 7.0) 
alone to reduce experimental error. 
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Figure 3.8: Complete inhibition of early C. albicans biofilms by treatment with 
denture cleanser (pH7). A) 4 h NT biofilms of all strains were grown on acrylic 
resin  denture  material  (1  cm
2)  sections  and  treated  with  Polident®  (pH  7.0)  ± 
brushing with a soft bristle toothbrush, and brushing with dentifrice. Regrowth of C. 
albicans  after  24  h  was  assessed  using  the  Miles  and  Misra  colony  counting 
technique.  B) SEM images showing yeast and hyphal C. albicans forms. 
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3.3.4 Daily intermittent treatment of biofilms  
 
The aim of this study was to investigate the effect of daily treatment of biofilms 
grown on denture material sections. Intermittent treatments with Polident® (pH 
7.0)  and  Polident®  (pH  8.6)  and  dentifrice/brushing  were  compared  to  daily 
sequential treatments with either denture cleanser alone. 
 
 3.3.4.1  Sequential  denture  cleansing  with  Polident®  (pH  8.6)  inhibits  biofilm 
growth 
  
Treatment of immature 4 h biofilms with Polident® (pH 7.0) initially inhibited C. 
albicans, but after three sequential treatments (24, 48 and 72 h) biofilm growth 
was observed, with approximately 8 x 10
5 CFU/mL detected at 72 h (Table 3.2).  
Comparison of treated and untreated controls demonstrated a significant reduction 
of cells at each time point (p<0.001). It was also shown that after each treatment C. 
albicans was able to regrow to cellular levels equivalent to 89%, 457% and 714% of 
the  4  h  untreated  biofilms,  indicating  that  the  denture  cleanser  was  unable  to 
completely  inhibit  and  kill  mature  biofilm  growth  (Figure  3.9).  Treatment  of 
immature 4 h biofilms with Polident® (pH 8.6)  was shown to inhibit the biofilm 
throughout  the  study,  with  no  growth  detected  for  any  of  the  treated  acrylic 
section  (Table  3.2).  No  regrowth  following  treatment  was  detected  at  each 
treatment phase (Figure 3.10).   65 
 
Figure 3.9: Daily sequential treatment with Polident® (pH 7.0) does not inhibit 
biofilm regrowth. An inoculum of 1 x 10
6 cells/mL from each NT isolate were added 
to a 1 cm
2 of denture acrylic section and incubated for 4 h to form an early biofilm, 
then treated directly with Polident® (pH 7.0) and sequentially thereafter at 24, 48 
and 72 h and the total viable cells enumerated. In parallel, acrylic sections that 
were  treated  at  each  time  point  were  reinoculated  into  RPMI and  the  levels  of 
regrowth  enumerated.  Untreated  biofilms  were  also  enumerated  throughout  the 
experiment.    66 
 
 
Figure 3.10: Daily sequential treatment with Polident® (pH 8.6) inhibits biofilm 
regrowth. An inoculum of 1 x 10
6 cells/mL from each NT isolate were added to a 1 
cm
2 of denture acrylic section and incubated for 4 h to form an early biofilm, then 
treated directly with Polident® (pH 8.6) and sequentially thereafter at 24, 48 and 
72 h and the total viable cells enumerated. In parallel, acrylic sections that were 
treated at each time point were reinoculated into RPMI and the levels of regrowth 
enumerated. Untreated biofilms were also enumerated throughout the experiment.  
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3.3.4.2  Intermittent  denture  cleansing  with  Polident®  (pH  7.0  and  8.6)  and 
Colgate® dentifrice and brushing does not inhibit biofilm growth 
 
Treatment  of  immature  4  h  biofilms  with  Polident®  (pH  7.0)  was  shown  to 
completely  inhibit  C.  albicans  biofilms  and  prevent  regrowth.  However,  it  was 
shown  subsequently  that  a  residual  population  of  cells  persisted  on  the  acrylic 
following brushing with dentifrice, with the 24 and 48 h treated sections supporting 
the growth of C. albicans, which resulted in a 12% and 181% regrowth, respectively, 
compared  to  the  untreated  4  h  control  (Table  3.2).    A  final  treatment  with 
Polident® (pH 7.0) was unable to inhibit biofilm growth, but a 26% reduction in 
biofilm was observed nonetheless. However, the mature biofilm was able to flourish 
following treatment, increasing the cellular viability by 628% to that of the initial 
biofilm (Figure 3.11). 
 
Treatment of immature 4 h biofilms with Polident® (pH 8.6) was also shown to 
completely inhibit C. albicans biofilms after 4 h, but following sequential brushing 
with Colgate® dentifrice residual levels were detected, which increased to 0.6% 
and 50% of their time matched controls at 24 and 48 h, respectively (Table 3.2). 
Regrowth of the biofilms was also observed at 24 h (8%) and 48 h (343%). A final 
Polident® (pH 8.6) treatment reduced the biofilm viability by 90%, but regrowth 
was  also  observed  from  the  residual  cells  to  434%  of  the  4  h  untreated  biofilm 
(Figure 3.12).  
 
SEM imaging confirmed that biofilm structure remains following cleansing with both 
Polident® formulations (Figure 3.13). 
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3.1
1: Daily intermittent treatment with Polident® (pH 7.0) does not inhibit biofilm 
regrowth. An inoculum of 1 x 10
6 cells/mL from each NT isolate were added to a 1 
cm
2 of denture acrylic section and incubated for 4 h to form an early biofilm, then 
treated directly  with  Polident®  (pH  7.0)  and  then  with  Colgate®  dentifrice and 
brushing at 24 and 48 h, followed by a final treatment with Polident® (pH 7.0) after 
72 h, and the total viable cells enumerated. In parallel, acrylic sections that were 
treated at each time point were reinoculated into RPMI and the levels of regrowth 
enumerated. Untreated biofilms were also enumerated throughout the experiment.  
 
 
Dentifrice 
+ brush 
Dentifrice 
+ brush   69 
 
Figure  3.12:  Daily  intermittent  treatment  with  Polident®  (pH  8.6)  does  not 
inhibit biofilm regrowth. An inoculum of 1 x 10
6 cells/mL from each NT isolate 
were added to a 1 cm
2 of denture acrylic section and incubated for 4 h to form an 
early biofilm, then treated directly with Polident® (pH 8.6) and then with Colgate® 
dentifrice  and  brushing  at  24  and  48  h,  followed  by  a  final  treatment  with 
Polident® (pH 8.6) after 72 h, and the total viable cells enumerated. In parallel, 
acrylic sections that were treated at each time point were reinoculated into RPMI 
and the levels of regrowth enumerated. Untreated biofilms were also enumerated 
throughout the experiment. 
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Table  3.2  Enumeration  of  Candida  albicans  cells  following  sequential  and  intermittent  treatment  on  acrylic 
sections at 4, 24, 48 and 72 h.  
 
 
 
 
 
 
 
*For intermittent treatment dentifrice and brushing performed at these time points 
ND No colonies detected for these treatments 
 
Polident® (pH 7.0)  Polident® (pH 8.6)   
Sequential  Intermittent  Sequential  Intermittent 
4  ND  ND  ND  ND 
24*  3.64 x 10
4 ± 7.02 x 10
3  9.32 x 10
4 ± 4.17 x 10
4  ND  2.76 x 10
4 ± 6.73 x 10
3 
48*  1.05 x 10
6 ± 1.78 x 10
5  4.23 x 10
5 ± 1.22 x 10
5  ND  1.35 x 10
6 ± 1.11 x 10
5 
72  7.73 x 10
5 ± 1.39 x 10
5  5.21 x 10
5 ± 8.84 x 10
4  ND  1.08 x 10
5 ± 1.77 x 10
4 71 
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Figure  3.13:  Residual  fungal  biofilm  remains  following  treatment  with 
denture  cleanser.  NT strain BC071 was grown on denture material for 4 h, 
treated with Polident denture cleansers (pH 7.0 and pH 8.6) and allowed to re 
grow overnight (24 h).  
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3.3.5 Killing efficacy of denture cleansers and dentifrice 
 
This study was designed to investigate killing activity of denture care products.  
Denture  cleansers  are  quicker  and  more  effective  at  inhibiting  biofilm 
metabolism than dentifrice. The metabolic reduction of all four isolates was 
evaluated using an XTT reduction assay. It was shown that dentifrice slurry was 
minimally  inhibitory,  reducing  the  metabolism  by  only  53%  after  10  min 
exposure. In contrast, Polident® (pH 7.0) was able to reduce the metabolism 
by 40% after 30 s, 75% by 3 min and 81% by 10 min. Polident® (pH 8.6) was 
highly  active,  inhibiting  the  metabolism  by  96.5%  after  only  30  s,  which 
reached 97% after 10 min.  
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Figure  3.14:  Time-kill  analysis  of  biofilms  treated  with  denture  care 
products  demonstrated  that  Polident®  (pH  8.6)  rapidly  kills  Candida 
albicans.  Biofilms  were  grown  in  96  well  microtitre  plates  for  24  h  before 
treatment with denture care products at time points of 0.5, 1, 3, 5 and 10 min. 
Metabolic activity of the treated biofilm was assessed by an XTT assay and the 
proportional decrease in viability compared to the untreated biofilms.  
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3.4 Use of alternative antimicrobials for the treatment of Candida albicans 
biofilms 
 
3.4.1 Introduction 
 
In  recent  years  there  has  been  a  wide  interest  in  novel  antimicrobial 
compounds used for the treatment of a variety of infections (Liu et al., 2010; 
Simmons  et  al.,  2010).  Current  studies  have  been  conducted  using 
ethylenediaminetetraacetic acid (EDTA) a divalent ion chelator (Ramage et al., 
2007) and farnesol; a quorum sensing molecule released by C. albicans which 
affects  phenotypic  switching  (Decanis  et  al.,  2009;  Ramage  et  al.,  2002b). 
Depending on the levels of fungal inhibition exhibited by these antimicrobials, 
there  is  possible  scope  for  incorporation  of  these  compounds  into  current 
products,  for  example  denture  cleansers  to  improve  the  action  of  these 
formulations. 
 
3.4.2 Optimisation of antimicrobial concentrations for efficient treatment of 
Candida albicans biofilms 
The aim of this study was to assess optimal concentrations of antimicrobials for 
the treatment of C. albicans biofilms. Biofilms were found to be inhibited by all 
treatments  (Figure  3.15).  Treatment  with  Polident®  (pH  7.0)  at  all 
concentrations reduced biofilm viability by 100%. Treatments with farnesol and 
EDTA  inhibited  biofilms  by  >25%  at  lowest  concentrations  used.  Increasing 
concentrations  of  EDTA  did  not  alter  effectiveness  of  treatment  while 
treatment with farnesol at 600  M reduced biofilms by >75%. 
 
3.4.3 Pre coating of 96 well microtitre plates with antimicrobial compounds 
 
Pre coating  with  all  antimicrobials  reduced  biofilm  formation.  Coating  with 
EDTA at the highest concentration negatively impacted biofilm formation by 
~75%.  Pre treatment  with  farnesol  and  Polident®  (pH  7.0)  reduced  biofilm 
formation by a mean of 25%. 75 
3.4.4 Pre coating of denture material sections with antimicrobial compounds 
To assess whether there was a similarity between biofilm inhibition by pre 
coating  of  substrates  with  antimicrobials;  denture  material  sections  were 
coated with above compounds prior to biofilm formation. Antimicrobials were 
allowed to evaporate prior to biofilm formation of NT III strain BC071 (Figure 
3.16). 
In contrast to section 3.5.3, statistically significant (**p< 0.01) levels of biofilm 
inhibition  were  observed  after  pre treatment  with  both  EDTA  and  denture 
cleanser. Pre coating of sections with farnesol did not affect biofilm formation.  
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Figure 3.15: Anti-biofilm action of antimicrobial compounds is less effective 
than treatment with denture cleanser. Biofilms of NT III strain (BC071) were 
grown for 24 h in 96 well plates. Treatment with farnesol, EDTA and Polident® 
(pH 7.0) was conducted for 4 h at decreasing concentrations. A reduction in 
biofilm viability was observed with increasing concentrations of farnesol.  
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Figure 3.16: Coating of 96 well microtitre plates with antimicrobials reduces 
subsequent  biofilm  formation.  Decreasing  concentrations  of  A)  farnesol,  B) 
EDTA and C) Polident® (pH 7.0) were aliqouted into 96 well microtitre plates 
and  allowed  to  evaporate.  24  h  biofilms  of  NT  III  strain  BC071  were 
subsequently formed.  
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Figure  3.17:  Coating  of  denture  material  with  antimicrobials  leads  to 
significant  reduction  in  biofilm  formation.  Pre sterilised  denture  material 
sections were coated with farnesol at a concentration of 600  M, EDTA at 500 
mM  and  neat  Polident®  (pH  7.0).  Excess  antimicrobial  was  allowed  to 
evaporate over 24 h. 24 h biofilms of NT III strain BC071 were grown on coated 
sections.  
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3.5  Innate  immune  response  to  Candida  albicans  biofilms  and  denture 
cleansers  
 
3.5.1 Introduction 
 
Successful colonisation of the oral epithelium by Candida species is associated 
with  the  recruitment  of  a  variety  of  host  responses.  In  particular  the 
recruitment  of  mediators  subsequently  results  in  the  release  of  pro 
inflammatory cytokines including IL 6, IL 8 and TNF α, which trigger phagocyte 
deployment to the site of infection (Mostefaoui et al., 2004).  Oral epithelial 
cell lines are commonly used as models for candidal infection in vivo (Dongari 
Bagtzoglou & Kashleva, 2003). 
 
3.5.2 Toxicity of antimicrobials to oral epithelial cells 
 
The aim of this study was to investigate the impact on viability of OKF6/TERT 
oral epithelial cells following treatment with EDTA, farnesol and Polident® (pH 
7.0).  Epithelial  cell  stimulation  with  neat  Polident®  (pH  7.0)  resulted  in 
complete  cell  death  after  1  min,  while  stimulation  with  EDTA  at  a 
concentration  of  500  mM  did  not  adversely  affect  cell  viability.  Stimulation 
with farnesol decreased cell viability in a time dependant manner, reducing to 
~70% and ~40% after 5 and 10 min, respectively (Figure 3.18). 80 
 
 
Figure  3.18:  Stimulation  of  oral  epithelial  cells  with  antimicrobial 
compounds affects viability. OKF6/TERT oral epithelial cells were cultured in 
24  well  tissue  culture  plates until  90 100% confluent. Cells  were  stimulated 
with Polident® (pH 7.0), EDTA and farnesol for 1, 5 and 10 min.  
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3.5.3 Gene expression of IL 8 in relation to Candida albicans planktonic and 
sessile cells 
 
Real time PCR was conducted to assess the levels of IL 8 gene expression from 
OKF6/TERT oral epithelial cells in relation to C. albicans grown in planktonic 
and biofilm forms. A cell culture model system was designed which facilitated 
direct stimulation of OKF6 epithelial cells with early/mature biofilms grown on 
denture material sections (Section 2.6.1.1). Gene regulation was standardised 
to  housekeeping  gene  GAPDH  and  zym  was  used  as  a  positive inflammatory 
agonist (Figure 3.19). Fold change was determined in relation to media control.  
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Figure  3.19: IL-8  expression  is  upregulated  in  response  to  early  Candida 
albicans biofilms. A) Gene expression following a 4 h epithelial cell stimulation 
and B) 24 h stimulation. IL 8 gene regulation in OKF6/TERT cells stimulated 
with planktonic  C. albicans cells, and early and mature biofilms, that were 
assessed  through  real time  PCR.  Fold  change  was  calculated  in  relation  to 
media control using GAPDH as a housekeeping gene. 
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3.5.4 OKF6/TERT stimulation with denture material particles 
 
The aim of this study was to assess whether manufactured denture material 
elicited  an  inflammatory  response  when  used  to  stimulate  OKF6/TERT  oral 
epithelial  cells  without  the  presence  of  yeast.  Following  a  4  and  24  h 
stimulation  with  both  concentrations  there  was  no  significant  IL 8  release 
associated  with  the  denture  material.  Stimulation  with  zym  resulted  in  a 
significant IL 8 response as illustrated in Figure 3.20. 
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Figure 3.20: OKF6/TERT stimulation with denture material does not result 
in a significant IL-8 response. OKF6/TERT oral epithelial cells were cultured 
until  confluent  and  stimulated  with  denture  material  particles  at 
concentrations of 10  g/mL and 10 mg/mL in cell culture media.   
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3.5.5 Comparison in immune response to treated and untreated biofilms used 
to stimulate oral epithelial cells 
 
OKF6/TERT epithelial cells grown in a confluent layer were used to assess the 
inflammatory  response  to  planktonic  and  sessile  C.  albicans  cells  (Section 
3.2.1).  DMSO,  amphotericin  B  and  zym  were  used  as  appropriate  controls. 
Planktonic and sessile cells were treated with denture cleanser for 3 min to 
investigate  whether  treatment  of  C.  albicans  cells  impacts  on  IL 8  release. 
Following a 4 h stimulation there was a significant (***p= < 0.001) IL 8 response 
observed only after zym stimulation. A 24 h epithelial cell stimulation resulted 
in elevated IL 8 release in response to both zym as well as early and mature 
biofilms. Treatment of biofilms and planktonic cells did not significantly alter 
the IL 8 response. 
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Figure  3.21:  Treatment  of  planktonic  and  sessile  Candida  albicans  cells 
does not impact IL-8 release. OKF6/TERT oral epithelial cells were stimulated 
with planktonic and sessile C. albicans cells of NT III strain BC071 for A) 4 and B) 
24 h. DMSO, Amphotericin B and zym were used as negative and a positive 
control respectively. 
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4. Discussion 
 
Candida  albicans  is  the  major  yeast  species  isolated  from  OPC  (including 
denture  induced  stomatitis)  cases  and  the  success  of  this  micro organism  is 
partly due to the ability to form biofilms on a variety of surfaces (Chandra et 
al., 2001a; Ramage et al., 2004; Redding et al., 2009). Whilst denture induced 
stomatitis is not life threatening per se, it affects a large proportion of the 15 
million denture wearers in the UK and is associated with undesirable symptoms 
(Coulthwaite & Verran, 2007). In addition to those clinically diagnosed with the 
disease,  an  equal  number  of  denture  wearers  are  asymptomatic.  Clinical 
management  is  required  in  all  cases  when  possible.  This  is  particularly 
important given the possibility of C. albicans to prosper within the oral cavity, 
which has been implicated to be associated with oral malignancies (Cannon & 
Chaffin,  1999;  Rautemaa  et  al.,  2007).  Therefore,  in  addition  to  daily  oral 
hygiene  practices,  denture  decontamination  is  pivotal  to  reducing  and 
eliminating  Candida  spp.  retained  upon  the  denture  as  adherent  biofilm 
communities.  
 
This  series  of  investigations  has  highlighted  potential  inadequacies  of  ‘gold 
standard’  oral  hygiene  techniques  against  C.  albicans  biofilms,  and 
demonstrated that sequential treatment with Polident® (pH 8.6) is superior to 
intermittent treatment regimens with either denture cleanser in combination 
with  dentifrice  and  brushing.  These  investigations  have  additionally 
demonstrated  the  potential  utility  of  morphological  modulators;  EDTA  and 
farnesol  to  augment  or  potentiate  the  activity  of  these  denture  cleansers. 
Nevertheless, based on the overall data C. albicans has the ability to persist 
upon denture acrylic, which following treatment retains the capacity to induce 
inflammatory mediators. The role of biofilms and denture disinfection will now 
be discussed.  
 
Biofilm  formation  is  an  adapted  lifestyle  that  enables  C.  albicans  to  thrive 
within the oral cavity on biological and innate substrates. Indeed, C. albicans 
biofilm formation is capable of providing defence from the immune system and 89 
contributes towards antifungal resistance (Ramage et al., 2009). In this study, 
a range of clinical C. albicans isolates from denture stomatitis patients (Coco 
et al., 2008) were tested for their ability to form biofilms in order to identify 
strains  for  subsequent  analysis.  Strains  representing  different  stages  of 
inflammation were selected, including suitable controls. It was established that 
these  strains  formed  visible  biofilms  to  different  extents  on  polystyrene 
substrates, irrespective of individual growth rates. Interestingly, those isolates 
from  Newton’s  type  inflammation  II  and  III  appeared  to  form  biofilms  with 
greater biomass than other strains. However, metabolic assessment of these 
strains  revealed  a  contrasting  pattern.  One  possible  explanation  is  that  the 
amount of biomass present was not indicative of cell viability and a proportion 
of the cell biomass might actually have been inactive. It is probable matrix 
material accounted for the majority of biomass present (Mukherjee & Chandra, 
2004).  
 
Studies have listed disadvantages in using the XTT assay to assess cell viability 
(Kuhn et al., 2003). Consequently, an experiment was designed that tested the 
sensitivity of the XTT assay.  The results demonstrated that the XTT assay is 
only  sensitive  to  a  C.  albicans  cell  concentration  of  1  x  10
5  cells/mL.  This 
implies that viable cells at a concentration < 1 x 10
5 cells/mL would not be 
detected and other assays measuring cell viability should be employed in future 
studies. The alamar blue indicator assay is commonly used as an alternative to 
the XTT assay due to a reported higher sensitivity to a variety of compounds 
(Uzunoglu et al., 2010). Other options for the assessment of Candida spp. cell 
vaibility include colony plate counting as well as use of various vital stains (Jin 
et al., 2005).   
 
Proteolytic and haemolytic activity was also variable amongst strains (data not 
shown).  Overall,  this  demonstrated  that  strain  variation  is  important  with 
respect to inducing overt disease in OPC patients. However, C. albicans innate 
ability to form biofilms remains problematic for treatment options. 
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Previous  studies  have  established  that  C.  albicans  biofilms  form  readily  on 
plastic surfaces (Tronchin et al., 1988; Ramage et al., 2001c). It was therefore 
also  important  to  establish  whether  biofilm  formation  occurs  similarly  on 
acrylic resin denture materials sections used in this study.  Results indicated 
that biofilms of an average cell density of 1 x 10
6 cells/mL were maintained on 
PMMA  denture  material  sections  over  a  period  of  48  h.  Resilient  biofilm 
structure  was  confirmed  by  SEM  imaging,  which  illustrated  both  yeast  and 
hyphal  C.  albicans  forms  indicative  of  a  biofilm  organisation.  Surface 
topography is an important factor for biofilm formation. Studies conducted by 
Verran  and  colleagues  (1997)  indicated  that  C.  albicans  cell  numbers  were 
significantly  higher  on  rough  versus  smooth  acrylic  and  silicone  surfaces 
following a 1 h incubation (Verran & Maryan, 1997). In contrast, PMMA surface 
roughness  did  not  upon  impact  biofilm  formation  in  a  recent  investigation. 
Marked deviations in biofilm formation were considered to be due to inter 
strain variation only (da Silva et al., 2010). 
 
The field of denture decontamination is still undergoing much research due to 
the general lack of efficiency of many commercially available products. DIS 
patients  often  treat  their  dentures  with  a  dentifrice  rather  than  denture 
cleanser (Barreiro et al., 2009). Previous research has indicated that brushing 
dentures with a dentifrice is an ineffective cleansing mechanism as damage to 
denture surface occurs over time, which then facilitates further attachment of 
microbial species (Charman et al., 2009). The results of these investigations 
confirmed that brushing dentures with dentifrice is a significantly less effective 
inhibition method of both early and mature C. albicans biofilms compared to 
treatment with tested denture cleansers.  
 
It  has  been  revealed  that  denture  wearers  often  lack  a  consistent  denture 
cleansing routine, which can impact greatly on their overall denture hygiene. In 
order to investigate this further, a study was devised a study to compare daily 
treatment of C. albicans biofilms with Polident® (pH 7.0) denture cleanser to 
daily  intermittent  treatment  with  Polident®  (pH  7.0)  and  brushing  with 
Colgate®  dentifrice.  Results  indicated  that  daily  treatment  with  either 91 
Polident® (pH 7.0) alone or intermittent treatment with Polident® (pH 7.0) 
and brushing with Colgate® dentifrice were ineffective at reducing C. albicans 
numbers once a mature biofilm had formed. This finding is in agreement with 
research outlining the difficulties associated with decontamination of biofilm 
covered surfaces, due to previously outlined biofilm characteristics as well as 
individual patient problems involved in routine cleansing (Kulak Ozkan et al., 
2002). Resistance to a variety of antifungals occurs due to protective matrix 
formation associated with C. albicans biofilm formation. Various explanations 
for the action of matrix material have been suggested (Al Fattani & Douglas, 
2006). One possible theory involves the glucan synthase gene; FKS1, which has 
been implicated as being crucial for resistance to a variety of antifungal agents 
(Nett et al., 2010). In addition, C. albicans cells remaining on decontaminated 
surfaces may exhibit the high persister cell phenotype, which has been isolated 
from  individuals  suffering  from  long term  candidal  carriage  (Lafleur  et  al., 
2010). 
 
The subsequent stage of this study involved repeating the above experiments 
with a novel formulation of the denture cleanser; Polident® (pH 8.6) which 
yielded a lower sessile MIC value compared to both  Polident® (pH 7.0) and 
Colgate®  dentifrice.    The  active  ingredients  of  Polident®  (pH  8.6)  and  the 
original Polident® (pH 7.0) are similar. However, Polident (pH 8.6) benefits 
from increased levels of oxidising agents present in the formulation. Oxidising 
agents  are  crucial  for  effective  denture  cleanser  formulation  due  to  their 
microbial cleansing effects (Pavarina et al., 2003). 
 
In contrast  to  my  previous  findings,  daily  treatment  of  C.  albicans  infected 
denture material sections with Polident® (pH 8.6) resulted in complete fungal 
inhibition throughout a 72 h time period. Together, this series of experiments 
indicated that daily treatment with Polident® (pH 7.0) as well as a combination 
of Polident® (pH 7.0) and Colgate® dentifrice was not adequate in maintaining 
low  C.  albicans  levels.    Dissimilarly,  combination  cleaning  with  alkaline 
peroxide  solution  and  brushing  with  a  dentifrice  yielded  the  highest 92 
decontamination effect on C. albicans mature biofilms compared to chemical 
or mechanical treatment alone (Paranhos et al., 2009). 
 
Since it has been revealed that candidal progression into a biofilm structure is 
a key virulence trait leading to pathogenesis, factors involved in the ‘switch’ 
between  planktonic  and  sessile  forms  are  a  crucial  target  for  future  drug 
development.  Farnesol  is  a  known  candidal  quorum  sensing  molecule 
responsible for inhibiting the modification from yeast to hyphae (Hornby et al., 
2001). In agreement with previous research, treatment of biofilms with varying 
concentrations of farnesol resulted in impaired biofilm formation (Ramage et 
al.,  2002b).  The  same  effect  was  observed  following  treatment  with  EDTA, 
which has been found to impact candidal filamentation through a mechanism of 
cation chelation (Ramage et al., 2007). EDTA demonstrated lower anti candidal 
activity; this is in contrast to previous findings which indicated that EDTA had 
greater  anti candidal  activity  than  a  variety  of  antifungal  drugs  as  well  as 
various denture hygiene products (Sen et al., 2000). A possible reason for this 
discrepancy could be the variation in C. albicans strains tested as well as the 
use of a variety of antifungals, which do not match those used in this study. 
 
A  study  was  also  designed  which  examined  the  anti biofilm  properties  of 
farnesol  and  EDTA  through  the  coating  of  plastic  substrates  with  these 
compounds prior to biofilm growth. Coating of both 96 well microtitre plates 
and PMMA denture material sections with set concentrations of Farnesol, EDTA 
and  Polident  (pH  7.0)  resulted  in  a  marked  decrease  in  biofilm  formation. 
Other  studies  conducted  using  PMMA  as  a  growth  substrate  for  C.  albicans 
biofilm formation indicate that use of EDTA is effective during decontamination 
of these surfaces without, importantly, affecting the surface roughness (Devine 
et al., 2007). 
 
Antimicrobial effects of farnesol are not fungal specific and have also been 
documented in regard to various bacteria including Staphylococci (Jabra Rizk 
et al., 2006a) and Streptococci species (Koo et al., 2002). Similarly, EDTA has 
been recognised as reducing the infectivity of herpes simplex virus (Devine et 93 
al., 2007). These species are known to be commonly isolated from the oral 
cavity.  This  suggests  that  there  are  wider  beneficial  aspects  of  using 
morphological  modulators  in  relation  to  treatment  of  oral  microorganisms. 
Future manipulations of morphological modulators such as EDTA and farnesol 
include the potential of combination with current denture hygiene products to 
aid  efficiency  against  a  variety  of  microorganisms.  It  has  recently  been 
demonstrated  that  treatment  of  a  range  of  microorganisms  with  farnesol 
increases  sensitivity  to  both  antibiotics  and  antifungals,  which  suggests 
implications for adjuvant properties of the molecule (Brehm Stecher & Johnson, 
2003; Jabra Rizk et al., 2006b). Likewise, EDTA has been used since the 1960’s 
due  to  the  synergistic  effects  observed  when  used  in  combination  with 
antimicrobials as well as antibiotics (Brown & Richards, 1965; Weiser et al., 
1969). In particular, EDTA has been utilised for catheter lock technology as 
recent studies have indicated that combinations of EDTA and amphotericin B 
lipid complexes result in significantly lowered Candida spp densities on silicone 
surfaces (Raad et al., 2008). 
 
Whilst EDTA and farnesol have proven antimicrobial effect, it is also important 
to consider host interactions. This aspect of the study investigated the innate 
immune  response  to  Candida  spp.  infection  and  specifically  the  impact  of 
biofilm treatment upon host inflammation. 
 
Initially, it was important to assess whether EDTA or farnesol were toxic to 
OKF6/TERT  oral  epithelial  cells  as  future  combinations  into  antimicrobial 
products could require antimicrobial to host cellular contact for mode of action. 
Following  epithelial  cell  stimulation  with  compounds,  an  XTT  assay  was 
conducted that evaluated cell viability post exposure. EDTA was found not to 
impact upon cell viability. In contrast, cell contact with farnesol resulted in 
decreased cell viability with time. Other studies assessing the toxicity of EDTA 
describe  this  compound  as  being  toxic  in  vivo,  but  only  at  higher 
concentrations than used in these studies (Lanigan & Yamarik, 2002). Previous 
studies  relating  to  farnesol  toxicity  demonstrated  that  cells  derived  from 
normal  tissue  exhibit  lower  levels  of  toxicity  to  farnesol  while  a  farnesol 94 
concentration  of  20   M  had  a  toxic  effect  on  HeLa  cells  (Yazlovitskaya  & 
Melnykovych, 1995).  
 
Polident® (pH 7.0) was also used to stimulate an oral epithelial cell line and 
resulted in complete cell death following a 1 min exposure. Limited intra oral 
exposure to human cells is advised in relation to this product as it is currently 
formulated for application out with the host. 
 
Due to the retention of biofilm biomass following a variety of decontamination 
procedures (Ramage et al., 2002c; Pusateri et al., 2009a; Jose et al., 2010) it 
was  essential  to  assess  whether  host  inflammation  occurred  independent  of 
treatment.  This can be achieved through monitoring of various inflammatory 
markers. In particular, high IL 8 production has been documented in response 
to epithelial and endothelial stimulation with C. albicans (Orozco et al., 2000).   
 
Therefore, IL 8 release by OKF6/TERT cells was quantitatively measured in this 
study as this pro inflammatory cytokine is recognised as being released at high 
levels in response to C. albicans stimulation (Dongari Bagtzoglou & Kashleva, 
2003).  IL 8  gene  expression  was  initially  assessed  through  real time  PCR.  
Stimulation  with  biofilms  resulted  in  upregulation  of  IL 8  gene  expression 
compared  to  OKF6/TERT  cell  stimulation  with  media  alone.  Eberhard  and 
colleagues established that significant IL 8 gene upregulation occurs during oral 
epithelial  cell  stimulation  with  S.  mutans  biofilms  (Eberhard  et  al.,  2009). 
Interestingly,  early  biofilms  induced  highest  IL 8  gene  upregulation  at  both 
time points while cell stimulation with mature biofilms resulted in upregulation 
at a similar level to planktonic C. albicans cells. A possible explanation for this 
is that extrapolymeric material formed during mature biofilm progression may 
result in a ‘shielding effect’ of the microorganism from cytokines released in 
response  to  infection.  This  phenomenon  has  been  reported  in  various 
microorganisms  including  Staphylococcus  epidermidis  (Richards  et  al.,  1994) 
and Pseudomonas aeruginosa (Bjarnsholt et al., 2010). 
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Gene expression results were in agreement with IL 8  ELISAs conducted; cell 
stimulation with early biofilms resulted in the highest IL 8 release. This was 
only  observed  after 24  h  epithelial  cell  stimulation  due  to  general  low  IL 8 
release observed following 4 h stimulation. Treatment of both planktonic C. 
albicans as well as biofilms with Polident® (pH 7.0) did not impact upon the 
inflammatory response. This suggests that the biofilm and associated material 
are responsible for the immune response discussed independent of whether the 
biofilm is viable during epithelial cell stimulation. 
 
Another  element  of  this  study  assessed  whether  sterile  denture  material 
positively influenced and therefore subsequently amplified the inflammatory 
response during Candida spp. infection. Varying concentrations of ground PMMA 
were used in contact with OKF6/TERT oral epithelial cells. Denture material 
did not significantly induce IL 8 stimulation by OKF6/TERT oral epithelial cells. 
This  suggests  that  inflammation  detected  in  DIS  occurs  only  in  response  to 
Candida spp. as well as other oral microorganisms. Contradicting evidence has 
been  elucidated  which  suggests  that  leaching  of  substances,  in  particular 
methyl methacrylate and formaldehyde from acrylic denture base materials, 
occurs  readily  during  patient  denture  wear.  Both  substances  are  associated 
with allergy and inflammation observed in a number of individuals. Pre soaking 
of dentures in water is therefore recommended prior to denture wear (Tsuchiya 
et al., 1994). 
 
Future work in relation to chemotherapeutic approaches for the treatment of C. 
albicans biofilms should concentrate on reducing the working concentration of 
Polident® (pH8.6) used for the treatment of biofilms on denture acrylic. MIC 
investigations  found that this  denture cleanser  functions at  a  quarter of its 
neat  concentration.  Reductions  in  working  concentration  may  allow  for 
combinations of other active ingredients to achieve a denture cleanser which 
not only permanently inhibits yeast viability but also physically removes the 
biofilm burden from denture surfaces. 
 96 
Raab and colleagues identified that ultrasonication is an effective method of 
denture  cleansing  (Raab  et  al.,  1991).  The  study  indicated  that  a  90  s 
treatment resulted in significant removal of denture plaque. In fact, this use of 
mechanical  technology  is  often  readily  available  for  patient  use  in  nursing 
homes or hospital environments (Roessler, 2003). Currently, ultrasonic baths 
are not purchased on a commercial scale for patient home use but are certainly 
a good future option for the provision of thoroughly decontaminated dentures. 
 
4.1 Conclusions 
 
C.  albicans  strains  isolated  from  varying  degrees  of  DIS  inflammation  cases 
represented contrasting metabolic and biofilm forming traits. Strains forming 
stable  biofilms  were  maintained  on  PMMA  denture  material  sections  at  an 
average density of 1 x 10
6 cells/mL throughout this study. Results indicated 
that brushing of denture material sections containing pre formed early biofilms 
with  dentifrice  and  soft  bristle  toothbrush  was  a  less  effective  method  of 
biofilm inhibition compared to treatment with both Polident (pH 7.0 and pH 
8.6). Only Polident (pH 8.6) was effective at fully inhibiting mature biofilms. 
Treatment  of  biofilms  with  morphological  modulators  farnesol  and  EDTA 
resulted in marked impairment in C. albicans biofilm formation. 
 
The  release  of  the  inflammatory  chemokine  IL 8  from  OKF6/TERT  oral 
epithelial cells in response to biofilm stimulation did not significantly change 
following treatment of biofilms with Polident (pH 7.0) suggesting that biofilm 
viability does not influence the host inflammatory response. 
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4.2 Future work 
 
Possible future suggestions to counteract ineffective treatment associated with 
mature  biofilm  formation  could  entail  twice  daily  denture  decontamination 
with denture cleanser or overnight removal of dentures following treatment 
with  denture  cleanser,  which  would  hinder  regrowth  of  yeast  due  to 
elimination  of  the  growth  environment.  Neither  of  these  methods  is 
particularly convenient therefore, patients should be advised to treat dentures 
with Polident® (pH 8.6) due to complete candidal inhibition documented as 
well as > 95% direct killing efficacy established following a 30 s treatment of 
mature biofilms. 
 
As these investigations are limited to the use of one yeast species it would be 
vital to repeat the various outlined studies with a number of micro organisms, 
both fungal and microbial, which are native to the oral cavity. 
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